_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725445927,5/25/2015 12:11:25,1642990832,5/25/2015 12:11:03,false,neodev,1,32438173,USA,VA,Manassas,207.244.77.2,[MANIFESTATION],[MANIFESTATION],WARFARIN STROKE,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:12:49,1642991341,5/25/2015 12:12:29,false,neodev,1,31743852,GBR,G5,Margate,85.210.126.147,[PREVENTS],[PREVENTS],WARFARIN reduced risk for STROKE,NONE,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:17:13,1642992528,5/25/2015 12:16:57,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],reduced,n/a,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:43:34,1642998027,5/25/2015 12:42:54,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],WARFARIN,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:43:49,1642998043,5/25/2015 12:43:29,false,neodev,1,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",A of an of,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:50:18,1642999182,5/25/2015 12:49:12,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,[OTHER],[OTHER],reduced risk,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:51:02,1642999338,5/25/2015 12:50:06,false,clixsense,1,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER] [PART_OF],"[PART_OF]
[OTHER]",reduced risk,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 12:53:03,1642999695,5/25/2015 12:52:32,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",meta analysis of 3 RCTs has shown WARFARIN given after MI achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,n/a,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:00:05,1643000986,5/25/2015 12:59:35,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],WARFARIN reduced risk for STROKE,na,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:04:56,1643001769,5/25/2015 13:04:43,false,neodev,1,31726043,GBR,H9,London,37.157.247.44,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],an,hhggh,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:06:56,1643002198,5/25/2015 13:06:17,false,elite,1,31722487,USA,IL,Chicago,99.198.108.118,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced risk for,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:07:22,1643002292,5/25/2015 13:06:46,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced risk for,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:08:45,1643002442,5/25/2015 13:05:53,false,tremorgames,1,31906954,USA,NY,Middletown,74.68.51.54,[PREVENTS],[PREVENTS],reduced risk for,Says reduces risk,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:10:05,1643002650,5/25/2015 13:09:47,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],shown that,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445927,5/25/2015 13:11:45,1643003032,5/25/2015 13:11:31,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.136,[TREATS],[TREATS],reduced risk,N/A,141,41,-1,146,49,TWrex-cause,804297-FS1,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN
725445928,5/25/2015 09:07:06,1642947482,5/25/2015 09:06:51,false,elite,1,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:15:59,1642948717,5/25/2015 09:15:39,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[SIDE_EFFECT],[SIDE_EFFECT],also seen,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:22:46,1642949723,5/25/2015 09:22:14,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:24:35,1642949925,5/25/2015 09:24:19,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",are also seen in patients with,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:28:02,1642950644,5/25/2015 09:27:50,false,elite,1,31537234,USA,UT,Hooper,50.186.66.157,[TREATS] [NONE],"[TREATS]
[NONE]",N/A,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:28:12,1642950654,5/25/2015 09:25:50,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also seen,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:32:09,1642951251,5/25/2015 09:31:55,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],seen in,n/a,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:41:19,1642952906,5/25/2015 09:40:24,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,n/a,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:51:48,1642954426,5/25/2015 09:50:59,false,prodege,1,2044524,GBR,Z7,Macclesfield,213.104.15.106,[NONE],[NONE],no,unsure,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:53:01,1642954585,5/25/2015 09:52:02,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,[SYMPTOM],[SYMPTOM],are seen in patients,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:53:58,1642954654,5/25/2015 09:53:46,false,elite,1,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]
[NONE]",N/A,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:53:59,1642954655,5/25/2015 09:53:38,false,elite,1,29216689,USA,"","",172.164.61.103,[MANIFESTATION],[MANIFESTATION],seen in,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:56:12,1642955067,5/25/2015 09:55:47,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],are seen,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 09:58:50,1642955641,5/25/2015 09:57:48,false,prodege,1,32672123,USA,CA,Irvine,192.171.229.225,[PART_OF],[PART_OF],seen in,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445928,5/25/2015 10:21:36,1642959713,5/25/2015 10:20:57,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],KERATOACANTHOMAS are seen with MTS,N/A,0,74,1,15,77,TWrex-cause,813561-FS1,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS
725445929,5/25/2015 12:11:41,1642990972,5/25/2015 12:11:27,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[LOCATION],[LOCATION],PTSD ANXIETY,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:13:13,1642991459,5/25/2015 12:12:50,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PTSD underdiagnosed reporting depression ANXIETY,NONE,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:17:32,1642992650,5/25/2015 12:17:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:43:55,1642998053,5/25/2015 12:43:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ANXIETY,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:44:12,1642998078,5/25/2015 12:43:52,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",or treatment,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:51:26,1642999398,5/25/2015 12:50:18,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],reporting,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:52:12,1642999587,5/25/2015 12:51:03,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],underdiagnosed reporting,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 12:53:42,1642999783,5/25/2015 12:53:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",PTSD may underdiagnosed patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,n/a,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:00:46,1643001101,5/25/2015 13:00:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PTSD in patients reporting ANXIETY,na,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:05:25,1643001827,5/25/2015 13:05:09,false,neodev,1.0,31726043,GBR,"","",88.150.175.253,[SYMPTOM],[SYMPTOM],in,jhjj,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:07:43,1643002344,5/25/2015 13:07:10,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",may be underdiagnosed,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:08:11,1643002384,5/25/2015 13:07:35,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],may be underdiagnosed in patients,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:09:42,1643002585,5/25/2015 13:08:46,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],patients reporting,Says that patients suffer from this,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:10:23,1643002714,5/25/2015 13:10:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],patients reporting,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445929,5/25/2015 13:11:58,1643003064,5/25/2015 13:11:46,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[CAUSES],[CAUSES],may be underdiagnosed,N/A,75,12,1,81,16,TWrex-cause,814650-FS1,Rationale • PTSD may be underdiagnosed in patients reporting depression or ANXIETY resulting in unsatisfactory treatment outcomes.,ANXIETY,PTSD
725445930,5/25/2015 10:46:26,1642974833,5/25/2015 10:46:05,false,elite,1,29216552,USA,"","",172.164.31.187,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 10:54:26,1642976060,5/25/2015 10:53:47,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],are contraindicated,n/a,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 11:30:21,1642982812,5/25/2015 11:30:07,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in,n,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 11:45:07,1642985709,5/25/2015 11:44:28,false,prodege,1,22031444,GBR,M4,Southampton,2.98.199.6,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in women who are or may become,N/a,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 11:47:57,1642986246,5/25/2015 11:47:29,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,[CONTRAINDICATES],[CONTRAINDICATES],are contraindicated in women who are pregnant,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:01:58,1642988876,5/25/2015 12:01:24,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[LOCATION],[LOCATION],LEUPROLIDE ACETATE INJECTION PREGNANCY,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:02:50,1642989118,5/25/2015 12:01:45,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated who are may become pregnant exclude,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:06:24,1642989794,5/25/2015 12:05:50,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CONTRAINDICATES],[CONTRAINDICATES],LEUPROLIDE ACETATE INJECTION are contraindicated in women pregnant,NONE,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:11:26,1642990840,5/25/2015 12:11:06,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:12:25,1642991218,5/25/2015 12:11:59,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy;,n/a,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:27:38,1642994637,5/25/2015 12:27:12,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in women who are or may become pregnant during therapy;,n/a,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:31:38,1642995499,5/25/2015 12:30:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ACETATE,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:35:30,1642996475,5/25/2015 12:34:20,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:36:10,1642996577,5/25/2015 12:35:48,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445930,5/25/2015 12:46:38,1642998496,5/25/2015 12:46:22,false,neodev,1,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,286,80,-1,294,108,TWrex-cause,803123-FS1,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   LEUPROLIDE ACETATE INJECTION and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude PREGNANCY before initiating therapy.",PREGNANCY,LEUPROLIDE ACETATE INJECTION
725445931,5/25/2015 08:06:35,1642936937,5/25/2015 08:06:04,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],was more effective,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:17:39,1642939057,5/25/2015 08:17:07,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],more effective for,n/a,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:21:51,1642939985,5/25/2015 08:21:40,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],hypertrophy,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:23:30,1642940340,5/25/2015 08:22:42,false,elite,1,29216801,USA,"","",172.162.14.122,[OTHER],[OTHER],and,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:27:28,1642941031,5/25/2015 08:26:51,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],more effective than,n/a,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:28:51,1642941173,5/25/2015 08:27:30,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[OTHER],[OTHER],for,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:29:54,1642941313,5/25/2015 08:28:45,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],Journal Club.,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:34:23,1642942042,5/25/2015 08:34:14,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],for,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:34:58,1642942167,5/25/2015 08:34:45,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],Hydrochlorothiazide,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:37:58,1642942804,5/25/2015 08:37:33,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Antihypertensive agents,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:45:02,1642943974,5/25/2015 08:44:14,false,pocketmoneygpt,1,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],more effective,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:49:43,1642944768,5/25/2015 08:49:30,false,elite,1,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],atenolol,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:54:38,1642945610,5/25/2015 08:54:13,false,neodev,1,29579905,GBR,"","",5.152.206.71,[SIDE_EFFECT],[SIDE_EFFECT],effective,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 08:59:46,1642946307,5/25/2015 08:59:35,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],hypertrophy,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445931,5/25/2015 09:03:04,1642946777,5/25/2015 09:01:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Losartan was more effective than atenolol,N/A,46,187,-1,75,195,TWrex-cause,804455-FS1,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN
725445932,5/25/2015 08:10:04,1642937739,5/25/2015 08:09:44,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],can be given,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:21:47,1642939965,5/25/2015 08:21:23,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],(which covers,n/a,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:24:52,1642940663,5/25/2015 08:24:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],metronidazole,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:34:01,1642941989,5/25/2015 08:33:23,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],given (which with,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:39:38,1642943114,5/25/2015 08:39:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],(which,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:40:32,1642943267,5/25/2015 08:39:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],(which covers,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:41:34,1642943362,5/25/2015 08:40:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:43:54,1642943777,5/25/2015 08:43:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],given covers INFECTION,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:52:54,1642945360,5/25/2015 08:52:43,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[LOCATION],[LOCATION],can,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:54:27,1642945591,5/25/2015 08:53:45,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],can be given,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 08:59:40,1642946294,5/25/2015 08:59:23,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 09:03:32,1642946832,5/25/2015 09:03:14,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[OTHER],[OTHER],given,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 09:12:40,1642948232,5/25/2015 09:12:26,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],metronidazole,N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 09:14:20,1642948437,5/25/2015 09:13:19,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],"Alternatively, AZITHROMYCIN 2 g po can given (which covers GONORRHEA AND CHLAMYDIAL INFECTION",N/A,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445932,5/25/2015 09:14:44,1642948466,5/25/2015 09:14:21,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],can be given (which covers in doses.,n/a,62,15,-1,95,27,TWrex-cause,803521-FS1,"Alternatively, AZITHROMYCIN 2 g po can be given (which covers GONORRHEA AND CHLAMYDIAL INFECTION with metronidazole 2 g po, both in single doses.",GONORRHEA AND CHLAMYDIAL INFECTION,AZITHROMYCIN
725445933,5/25/2015 10:45:08,1642974552,5/25/2015 10:44:43,false,elite,1.0,29216552,USA,"","",172.164.31.187,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",vaccine that associated with,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 10:46:51,1642974920,5/25/2015 10:46:27,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],protects against,n/a,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 10:50:37,1642975521,5/25/2015 10:50:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],vaccine that protects,n/a,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 10:52:35,1642975820,5/25/2015 10:51:51,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],protects against those that have been associated with,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 11:29:26,1642982655,5/25/2015 11:29:09,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 11:43:42,1642985443,5/25/2015 11:43:13,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],A vaccine that protects,N/a,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 11:46:29,1642985984,5/25/2015 11:45:55,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 11:56:33,1642987889,5/25/2015 11:56:07,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[PREVENTS],[PREVENTS],HPV GENITAL WARTS,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 11:57:57,1642988113,5/25/2015 11:56:42,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:04:56,1642989477,5/25/2015 12:04:29,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[PREVENTS],[PREVENTS],HPV A vaccine protects associated with GENITAL WARTS,NONE,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:10:09,1642990524,5/25/2015 12:09:41,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],protects against,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:11:23,1642990829,5/25/2015 12:11:09,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:25:08,1642994184,5/25/2015 12:24:43,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],"HPV v. A vaccine that protects against several types of human papillomavirus infection,",n/a,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:29:49,1642995145,5/25/2015 12:27:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],GENITAL WARTS,N/A,142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445933,5/25/2015 12:32:12,1642995626,5/25/2015 12:29:27,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,"I didn't select ""none""...",142,0,1,154,3,TWrex-cause,814775-FS1,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with GENITAL WARTS and cervical cancer.",GENITAL WARTS,HPV
725445934,5/25/2015 10:45:37,1642974709,5/25/2015 10:45:09,false,elite,1.0,29216552,USA,"","",172.164.31.187,[PREVENTS],[PREVENTS],in the prevention of,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 10:47:10,1642974965,5/25/2015 10:46:52,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention of,n/a,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 10:50:52,1642975547,5/25/2015 10:50:38,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],in the prevention of,n/a,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 11:29:39,1642982711,5/25/2015 11:29:29,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],prevention of,n,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 11:44:00,1642985519,5/25/2015 11:43:43,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],in the prevention of,N/a,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 11:46:51,1642986050,5/25/2015 11:46:30,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS],[PREVENTS],in the prevention of,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 11:59:19,1642988358,5/25/2015 11:57:58,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],prevention,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 11:59:25,1642988386,5/25/2015 11:56:36,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[TREATS],[TREATS],ORAL ONDANSETRON,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:05:25,1642989604,5/25/2015 12:04:57,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[PREVENTS],[PREVENTS],ORAL ONDANSETRON in the prevention of EMESIS,NONE,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:10:26,1642990574,5/25/2015 12:10:11,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[PREVENTS],[PREVENTS],prevention of,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:11:36,1642990938,5/25/2015 12:11:23,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevention,n/a,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:26:32,1642994430,5/25/2015 12:25:20,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients,n/a,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:30:30,1642995303,5/25/2015 12:29:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],EMESIS,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:33:08,1642995836,5/25/2015 12:32:13,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[PREVENTS],[PREVENTS],prevention,Prevention,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445934,5/25/2015 12:35:24,1642996461,5/25/2015 12:34:37,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [SIDE_EFFECT],"[SIDE_EFFECT]
[PART_OF]",Efficacy of of,N/A,88,50,-1,93,66,TWrex-cause,804854-FS1,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of ORAL ONDANSETRON in the prevention of EMESIS in outpatients receiving cyclophosphamide based chemotherapy.",EMESIS,ORAL ONDANSETRON
725445935,5/25/2015 12:09:28,1642990402,5/25/2015 12:09:02,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TYPE I PSEUDOHYPOPARATHYROIDISM HYPOCALCEMIA,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:12:08,1642991070,5/25/2015 12:11:45,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TYPE I PSEUDOHYPOPARATHYROIDISM distinguished presence of HYPOCALCEMIA,NONE,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:15:31,1642992127,5/25/2015 12:14:42,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],distinguished by the presence,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:16:38,1642992351,5/25/2015 12:16:22,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],presence of,n/a,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:42:24,1642997771,5/25/2015 12:41:44,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPOCALCEMIA,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:43:07,1642997973,5/25/2015 12:42:45,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of of,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:48:09,1642998760,5/25/2015 12:47:30,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],distinguished by the presence of,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:52:05,1642999577,5/25/2015 12:51:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,n/a,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 12:59:02,1643000793,5/25/2015 12:58:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[LOCATION],[LOCATION],TYPE I PSEUDOHYPOPARATHYROIDISM distinguished by HYPOCALCEMIA,na,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:04:18,1643001653,5/25/2015 13:04:07,false,neodev,1.0,31726043,GBR,"","",5.152.201.76,[CAUSES],[CAUSES],HYPOCALCEMIA,hghgh,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:05:02,1643001771,5/25/2015 13:04:10,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",can be distinguished by,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:05:06,1643001780,5/25/2015 13:04:26,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],distinguished by the presence of,Says that this happens during those disease,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:05:16,1643001811,5/25/2015 13:04:31,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",can be distinguished by the presence of,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:09:33,1643002570,5/25/2015 13:09:16,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],distinguished by the presence,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445935,5/25/2015 13:11:14,1643002950,5/25/2015 13:10:48,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[MANIFESTATION],[MANIFESTATION],presence of,N/A,72,0,1,83,31,TWrex-cause,813445-FS1,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM
725445936,5/25/2015 08:01:45,1642936147,5/25/2015 08:01:05,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:13:58,1642938387,5/25/2015 08:13:27,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:17:07,1642938981,5/25/2015 08:16:53,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:17:23,1642939007,5/25/2015 08:17:08,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:17:50,1642939093,5/25/2015 08:17:26,false,elite,1.0,29216801,USA,"","",172.162.14.122,[OTHER],[OTHER],in the treatment of,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:19:24,1642939427,5/25/2015 08:18:49,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:19:30,1642939471,5/25/2015 08:19:17,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:21:43,1642939955,5/25/2015 08:21:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],in the treatment of,n/a,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:21:59,1642940004,5/25/2015 08:21:19,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [TREATS] [PART_OF],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",with treatment of,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:25:27,1642940717,5/25/2015 08:24:04,false,prodege,1,23930372,GBR,E2,Hastings,2.103.22.113,[TREATS],[TREATS],treatment,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:25:41,1642940768,5/25/2015 08:25:07,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.116.56,[TREATS],[TREATS],ALL TRANS RETINOIC ACID treatment ACUTE PROMYELOCYTIC,NONE,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:31:59,1642941563,5/25/2015 08:31:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:32:37,1642941705,5/25/2015 08:32:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:34:25,1642942062,5/25/2015 08:33:01,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatment,selected treats,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445936,5/25/2015 08:44:50,1642943896,5/25/2015 08:44:27,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,119,75,-1,146,98,TWrex-cause,803402-FS1,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with ALL TRANS RETINOIC ACID in the treatment of ACUTE PROMYELOCYTIC LEUKEMIA",ACUTE PROMYELOCYTIC LEUKEMIA,ALL TRANS RETINOIC ACID
725445937,5/25/2015 11:53:55,1642987489,5/25/2015 11:53:36,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],for,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:08:59,1642990286,5/25/2015 12:08:21,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[PART_OF],[PART_OF],BASAL INSULIN GLARGINE TYPE 2 DIABETES:,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:11:43,1642990975,5/25/2015 12:10:59,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[OTHER],[OTHER],BASAL INSULIN GLARGINE versus biaspart insulin for TYPE 2 DIABETES:,NONE,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:14:39,1642991905,5/25/2015 12:13:50,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],for,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:16:20,1642992244,5/25/2015 12:15:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],for,n/a,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:40:54,1642997468,5/25/2015 12:40:36,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],a multicentre randomised trial.,n/a,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:41:44,1642997633,5/25/2015 12:41:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TYPE 2 DIABETES:,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:42:41,1642997846,5/25/2015 12:42:14,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A],[IS_A],a,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:47:30,1642998638,5/25/2015 12:46:53,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 12:58:32,1643000705,5/25/2015 12:57:51,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BASAL INSULIN GLARGINE for TYPE 2 DIABETES:,na,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 13:03:58,1643001613,5/25/2015 13:03:35,false,neodev,1.0,31726043,GBR,"","",5.152.201.76,[MANIFESTATION],[MANIFESTATION],insulin,hh,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 13:04:04,1643001637,5/25/2015 13:03:12,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",versus twice daily biaspart insulin,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 13:04:26,1643001668,5/25/2015 13:03:32,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PREVENTS] [ASSOCIATED_WITH],"[PREVENTS]
[ASSOCIATED_WITH]",versus twice daily biaspart insulin for,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 13:04:25,1643001692,5/25/2015 13:03:25,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],versus,It's comparing 2 treatment methods,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445937,5/25/2015 13:09:15,1643002523,5/25/2015 13:08:53,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,93,30,-1,107,52,TWrex-cause,800894-FS1,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
725445938,5/25/2015 08:03:19,1642936493,5/25/2015 08:02:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],initial treatment of,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:15:14,1642938606,5/25/2015 08:14:57,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:17:48,1642939089,5/25/2015 08:17:36,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:19:17,1642939385,5/25/2015 08:18:37,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:19:46,1642939524,5/25/2015 08:19:12,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],for initial treatment of,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:20:13,1642939650,5/25/2015 08:20:00,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:22:47,1642940209,5/25/2015 08:22:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],initial treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:23:32,1642940369,5/25/2015 08:23:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],initial treatment,n/a,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:23:49,1642940419,5/25/2015 08:23:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH] [PART_OF] [TREATS],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with treatment of a,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:28:10,1642941092,5/25/2015 08:27:22,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.116.56,[TREATS],[TREATS],RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C:,NONE,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:33:19,1642941827,5/25/2015 08:33:08,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:34:26,1642942071,5/25/2015 08:34:06,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:37:41,1642942767,5/25/2015 08:37:04,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:45:38,1642944053,5/25/2015 08:45:23,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445938,5/25/2015 08:51:50,1642945159,5/25/2015 08:51:21,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF] [TREATS] [IS_A],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with treatment of a,N/A,153,118,-1,171,127,TWrex-cause,800654-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN
725445939,5/25/2015 09:39:55,1642952722,5/25/2015 09:39:42,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PREVENTS] [TREATS] [MANIFESTATION] [CONTRAINDICATES] [ASSOCIATED_WITH] [SIDE_EFFECT] [NONE],"[TREATS]
[PREVENTS]
[MANIFESTATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:03:47,1642956474,5/25/2015 10:03:22,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [SIDE_EFFECT] [NONE],"[PREVENTS]
[SIDE_EFFECT]
[NONE]",N/A,N/A,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:06:43,1642956905,5/25/2015 10:05:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA REFERENCES 1.",n/a,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:07:38,1642956997,5/25/2015 10:06:15,false,elite,1.0,29216689,USA,"","",172.164.61.103,[OTHER],[OTHER],MD MSC DENVER VA MEDICAL CENTER DENVER,N/A,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:09:29,1642957232,5/25/2015 10:08:11,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[NONE],[NONE],none,Is medical centre,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:36:23,1642967560,5/25/2015 10:35:34,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[OTHER],[OTHER],REFERENCES,Academic qualification,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:39:09,1642970273,5/25/2015 10:38:17,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],"MD DENVER VA MEDICAL CENTER DENVER Colorado,",N/A,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:41:12,1642972053,5/25/2015 10:40:47,false,elite,1.0,29216552,USA,"","",172.164.31.187,[OTHER],[OTHER],MD MSC DENVER VA MEDICAL CENTER DENVER,N/A,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:42:17,1642972877,5/25/2015 10:41:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[IS_A],[IS_A],Allan V. Prochazka MD,n/a,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:44:09,1642974024,5/25/2015 10:43:35,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's no relation between the terms.,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 10:46:03,1642974755,5/25/2015 10:45:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,these are doctor's credentials and office,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 11:25:34,1642981984,5/25/2015 11:24:19,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],"Colorado,",part of,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 11:39:26,1642984532,5/25/2015 11:39:03,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/a,Unrelated terms,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 11:41:58,1642984998,5/25/2015 11:41:23,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation.,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445939,5/25/2015 11:43:50,1642985468,5/25/2015 11:43:09,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[PART_OF],[PART_OF],MSC,n/a,19,22,-1,20,57,TWrex-cause,803525-FS1,"Allan V. Prochazka MD MSC DENVER VA MEDICAL CENTER DENVER Colorado, USA    REFERENCES  1.",MD,MSC DENVER VA MEDICAL CENTER DENVER
725445940,5/25/2015 08:06:49,1642936972,5/25/2015 08:06:36,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:17:53,1642939105,5/25/2015 08:17:40,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],for,n/a,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:22:06,1642940019,5/25/2015 08:21:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:23:50,1642940425,5/25/2015 08:23:32,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:28:05,1642941065,5/25/2015 08:27:30,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],for,n/a,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:32:16,1642941624,5/25/2015 08:31:05,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:32:43,1642941707,5/25/2015 08:30:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:35:11,1642942250,5/25/2015 08:35:00,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:38:15,1642942857,5/25/2015 08:37:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:46:15,1642944138,5/25/2015 08:45:03,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[SYMPTOM],[SYMPTOM],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:50:00,1642944844,5/25/2015 08:49:47,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 08:54:56,1642945664,5/25/2015 08:54:41,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 09:00:01,1642946338,5/25/2015 08:59:49,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 09:04:26,1642946894,5/25/2015 09:03:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],THALIDOMIDE for APHTHOUS ULCERS,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445940,5/25/2015 09:08:05,1642947637,5/25/2015 09:07:20,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,16,0,-1,30,11,TWrex-cause,804857-FS1,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
725445941,5/25/2015 10:47:54,1642975111,5/25/2015 10:47:31,false,elite,1.0,29216552,USA,"","",172.164.31.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 11:31:07,1642982961,5/25/2015 11:30:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Screen for,n,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 11:46:25,1642985953,5/25/2015 11:45:59,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[MANIFESTATION],[MANIFESTATION],Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,N/a,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 11:49:30,1642986581,5/25/2015 11:48:52,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Screen in men and women with,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:03:45,1642989258,5/25/2015 12:03:03,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[SYMPTOM],[SYMPTOM],CELIAC DISEASE INFERTILITY,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:05:29,1642989620,5/25/2015 12:04:39,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],Screen unexplained,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:07:41,1642990048,5/25/2015 12:07:15,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[MANIFESTATION],[MANIFESTATION],Screen CELIAC DISEASE unexplained INFERTILITY,NONE,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:12:37,1642991298,5/25/2015 12:12:17,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Screen for,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:13:15,1642991462,5/25/2015 12:13:00,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Screen,n/a,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:29:07,1642994937,5/25/2015 12:28:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,n/a,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:33:38,1642996007,5/25/2015 12:32:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CELIAC DISEASE,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:37:13,1642996855,5/25/2015 12:37:00,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:38:06,1642996994,5/25/2015 12:37:05,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],Screen for CELIAC DISEASE,N/A,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:47:27,1642998636,5/25/2015 12:47:18,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445941,5/25/2015 12:48:34,1642998887,5/25/2015 12:47:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],CELIAC DISEASE in women with INFERTILITY,na,91,42,1,101,56,TWrex-cause,814537-FS1,B]  Specific recommendation: • Screen for CELIAC DISEASE in men and women with unexplained INFERTILITY,INFERTILITY,CELIAC DISEASE
725445942,5/25/2015 08:03:34,1642936556,5/25/2015 08:03:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:15:32,1642938656,5/25/2015 08:15:16,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:18:03,1642939132,5/25/2015 08:17:51,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:19:30,1642939469,5/25/2015 08:19:18,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:20:27,1642939677,5/25/2015 08:20:14,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:20:30,1642939691,5/25/2015 08:19:48,false,elite,1.0,29216801,USA,"","",172.162.14.122,[CAUSES],[CAUSES],caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:23:32,1642940366,5/25/2015 08:22:49,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:24:06,1642940500,5/25/2015 08:23:47,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by,n/a,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:24:16,1642940558,5/25/2015 08:23:55,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",is caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:29:27,1642941231,5/25/2015 08:28:45,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.116.56,[CAUSES],[CAUSES],STREPTOCOCCAL PHARYNGITIS caused by GABHS,NONE,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:33:35,1642941887,5/25/2015 08:33:20,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:34:47,1642942124,5/25/2015 08:34:28,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:38:08,1642942821,5/25/2015 08:37:45,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:47:17,1642944257,5/25/2015 08:46:24,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],caused,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445942,5/25/2015 08:52:14,1642945222,5/25/2015 08:51:57,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",is caused by,N/A,0,47,1,24,52,TWrex-cause,810336-FS1,STREPTOCOCCAL PHARYNGITIS is usually caused by GABHS,STREPTOCOCCAL PHARYNGITIS,GABHS
725445943,5/25/2015 08:02:49,1642936368,5/25/2015 08:02:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],α with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:14:56,1642938529,5/25/2015 08:14:27,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],associated,n/a,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:17:35,1642939030,5/25/2015 08:17:22,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:18:36,1642939262,5/25/2015 08:17:59,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],effects,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:19:10,1642939340,5/25/2015 08:18:34,false,elite,1.0,29216801,USA,"","",172.162.14.122,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:19:59,1642939562,5/25/2015 08:19:46,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],clinical,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:22:31,1642940163,5/25/2015 08:21:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:23:12,1642940307,5/25/2015 08:22:49,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with with with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:23:14,1642940312,5/25/2015 08:22:25,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER],[OTHER],"safety, tolerance,",n/a,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:27:14,1642940951,5/25/2015 08:26:20,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.116.56,[TREATS],[TREATS],Interferon α with ZIDOVUDINE: associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.,NONE,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:33:06,1642941766,5/25/2015 08:32:53,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:34:06,1642941992,5/25/2015 08:33:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],patients with Kaposi sarcoma,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:37:02,1642942676,5/25/2015 08:36:13,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:45:20,1642944040,5/25/2015 08:45:07,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445943,5/25/2015 08:51:18,1642945039,5/25/2015 08:50:35,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",with effects with with,N/A,137,19,-1,170,29,TWrex-cause,800417-FS1,"Interferon  α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE
725445944,5/25/2015 08:04:20,1642936649,5/25/2015 08:04:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:16:14,1642938834,5/25/2015 08:15:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:18:27,1642939219,5/25/2015 08:18:18,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:20:55,1642939812,5/25/2015 08:20:42,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:21:04,1642939836,5/25/2015 08:20:10,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],discontinue,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:21:22,1642939864,5/25/2015 08:20:58,false,elite,1.0,29216801,USA,"","",172.162.14.122,[PREVENTS],[PREVENTS],"is detected, discontinue",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:24:50,1642940641,5/25/2015 08:24:31,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",discontinue,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:24:59,1642940668,5/25/2015 08:24:37,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:25:16,1642940686,5/25/2015 08:24:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:34:03,1642941988,5/25/2015 08:33:50,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:35:46,1642942402,5/25/2015 08:35:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],discontinue as soon as possible.,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:40:25,1642943233,5/25/2015 08:39:16,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",discontinue,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:48:40,1642944543,5/25/2015 08:48:26,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:52:56,1642945362,5/25/2015 08:52:39,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is,N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445944,5/25/2015 08:58:51,1642946228,5/25/2015 08:58:37,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,51,TWrex-cause,803094-FS1,"•  If PREGNANCY is detected, discontinue FOSINOPRIL as soon as possible.",PREGNANCY,FOSINOPRIL
725445945,5/25/2015 11:47:25,1642986134,5/25/2015 11:47:09,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],treatment of,N/a,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 11:50:51,1642986903,5/25/2015 11:50:38,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment of,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:05:52,1642989741,5/25/2015 12:05:13,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[TREATS],[TREATS],RECOMBINANT LEUKOCYTE INTERFERON MYCOSIS FUNGOIDES.,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:08:40,1642990245,5/25/2015 12:07:48,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treatment of,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:08:52,1642990277,5/25/2015 12:08:32,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A treatment of MYCOSIS FUNGOIDES.,NONE,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:13:36,1642991616,5/25/2015 12:13:15,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],in the treatment,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:14:02,1642991765,5/25/2015 12:13:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:30:49,1642995339,5/25/2015 12:30:32,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],treatment of MYCOSIS FUNGOIDES.,n/a,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:35:58,1642996519,5/25/2015 12:35:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MYCOSIS FUNGOIDES.,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:38:32,1642997051,5/25/2015 12:38:09,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:42:02,1642997690,5/25/2015 12:40:54,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SIDE_EFFECT],[SIDE_EFFECT],RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of,N/A/,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:48:12,1642998771,5/25/2015 12:48:00,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:48:33,1642998886,5/25/2015 12:48:25,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:50:22,1642999188,5/25/2015 12:49:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in treatment of MYCOSIS FUNGOIDES.,na,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445945,5/25/2015 12:52:23,1642999606,5/25/2015 12:51:22,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[OTHER],[OTHER],treatment,n/a,101,40,-1,117,80,TWrex-cause,803372-FS1,"Simoni R, Cavalieri R, Coppola G et al. RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A in the treatment of MYCOSIS FUNGOIDES.",MYCOSIS FUNGOIDES,RECOMBINANT LEUKOCYTE INTERFERON ALFA 2A
725445946,5/25/2015 08:08:10,1642937278,5/25/2015 08:07:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],within the,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:19:17,1642939384,5/25/2015 08:18:56,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],within,n/a,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:23:05,1642940275,5/25/2015 08:22:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],cause,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:26:14,1642940840,5/25/2015 08:25:44,false,elite,1.0,29216801,USA,"","",172.162.14.122,[CAUSES],[CAUSES],possible cause of,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:34:51,1642942129,5/25/2015 08:33:59,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION] [ASSOCIATED_WITH] [OTHER],"[MANIFESTATION]
[ASSOCIATED_WITH]
[OTHER]",containing within the,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:36:11,1642942461,5/25/2015 08:35:58,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],nephropathy,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:36:54,1642942615,5/25/2015 08:35:43,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",OF of cause of of or within,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:40:26,1642943254,5/25/2015 08:40:01,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],within KIDNEYS,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:49:40,1642944761,5/25/2015 08:48:44,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[LOCATION] [SYMPTOM] [SIDE_EFFECT],"[LOCATION]
[SYMPTOM]
[SIDE_EFFECT]",possible cause within the KIDNEYS,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:51:00,1642945014,5/25/2015 08:50:48,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cause,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 08:56:56,1642945940,5/25/2015 08:56:20,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH] [CAUSES] [IS_A],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",OF of cause of is of within,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 09:01:14,1642946589,5/25/2015 09:00:55,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],cause,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 09:08:05,1642947636,5/25/2015 09:06:54,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[LOCATION],[LOCATION],formation of cysts or pockets containing fluid within the KIDNEYS,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 09:10:43,1642947943,5/25/2015 09:10:27,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cause,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445946,5/25/2015 09:11:26,1642948020,5/25/2015 09:10:34,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",OF of cause of of or within,N/A,32,6,-1,38,39,TWrex-cause,802042-FS1,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS
725445947,5/25/2015 08:10:55,1642937905,5/25/2015 08:10:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:22:32,1642940157,5/25/2015 08:22:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:26:06,1642940825,5/25/2015 08:25:42,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:34:54,1642942146,5/25/2015 08:34:38,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],in the initial treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:40:46,1642943289,5/25/2015 08:40:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:42:36,1642943566,5/25/2015 08:41:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],initial treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:43:58,1642943778,5/25/2015 08:43:21,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:45:15,1642944025,5/25/2015 08:44:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:53:52,1642945502,5/25/2015 08:53:33,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 08:56:25,1642945872,5/25/2015 08:55:55,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 09:01:01,1642946548,5/25/2015 09:00:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 09:04:30,1642946949,5/25/2015 09:04:16,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 09:13:53,1642948402,5/25/2015 09:13:26,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 09:15:49,1642948645,5/25/2015 09:15:27,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],in the treatment of,n/a,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445947,5/25/2015 09:16:41,1642948824,5/25/2015 09:15:52,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,138,102,-1,155,109,TWrex-cause,803651-FS1,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725445948,5/25/2015 08:07:16,1642937032,5/25/2015 08:06:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],Other signs,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:18:14,1642939187,5/25/2015 08:17:54,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],signs include,n/a,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:22:20,1642940067,5/25/2015 08:22:08,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PART_OF],[PART_OF],including,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:24:24,1642940584,5/25/2015 08:23:53,false,elite,1.0,29216801,USA,"","",172.162.14.122,[SIDE_EFFECT],[SIDE_EFFECT],including,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:33:17,1642941823,5/25/2015 08:32:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],signs,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:34:02,1642941986,5/25/2015 08:32:21,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",of other caused by of or,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:35:25,1642942307,5/25/2015 08:35:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],phenomenon,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:39:00,1642942946,5/25/2015 08:38:19,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],Other signs include,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:47:27,1642944278,5/25/2015 08:46:23,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",Other signs include changes including,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:50:17,1642944888,5/25/2015 08:50:03,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PART_OF],[PART_OF],including,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 08:55:38,1642945732,5/25/2015 08:55:00,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[OTHER] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[OTHER]",Other of caused by of or,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 09:00:16,1642946391,5/25/2015 09:00:03,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 09:05:25,1642947157,5/25/2015 09:04:29,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other signs include,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 09:09:15,1642947780,5/25/2015 09:08:10,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[OTHER] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",Other of caused by of or,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445948,5/25/2015 09:09:44,1642947827,5/25/2015 09:09:13,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,31,129,1,42,141,TWrex-cause,811434-FS1,"Other signs include pleuritis, PERICARDITIS myocarditis, neurological changes including behavioral changes and seizure activity (NEURAL LUPUS), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",PERICARDITIS,NEURAL LUPUS
725445949,5/25/2015 09:29:41,1642950873,5/25/2015 09:29:28,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],sometimes accompanied by,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 09:37:28,1642952318,5/25/2015 09:37:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,n/a,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 09:38:18,1642952449,5/25/2015 09:38:07,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PREVENTS] [CONTRAINDICATES] [SIDE_EFFECT] [LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[CONTRAINDICATES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:00:58,1642955944,5/25/2015 10:00:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION,n/a,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:01:26,1642956071,5/25/2015 10:01:00,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [PART_OF] [NONE],"[TREATS]
[PART_OF]
[NONE]",N/A,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:03:30,1642956421,5/25/2015 10:03:06,false,elite,1.0,29216689,USA,"","",172.164.61.103,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",accompanied by or,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:06:13,1642956857,5/25/2015 10:05:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],accompanied by,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:33:21,1642965065,5/25/2015 10:33:00,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],sometimes accompanied,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:35:22,1642966667,5/25/2015 10:34:05,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],TEMPOROMANDIBULAR JOINT MOVEMENT accompanied by JOINT DYSFUNCTION,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:38:14,1642969379,5/25/2015 10:37:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],sometimes accompanied by,n/a,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:39:00,1642970122,5/25/2015 10:38:32,false,elite,1.0,29216552,USA,"","",172.164.31.187,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",sometimes accompanied by,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:39:55,1642970961,5/25/2015 10:39:30,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",accompanied by,N/A,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 10:43:14,1642973593,5/25/2015 10:42:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],sometimes accompanied by,n/a,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 11:21:55,1642981217,5/25/2015 11:21:32,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],accompanied by,n,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445949,5/25/2015 11:37:37,1642984298,5/25/2015 11:37:09,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],sometimes accompanied,N/a,38,104,-1,69,121,TWrex-cause,802845-FS1,"In dentistry, a noise associated with TEMPOROMANDIBULAR JOINT MOVEMENT sometimes accompanied by pain or JOINT DYSFUNCTION",TEMPOROMANDIBULAR JOINT MOVEMENT,JOINT DYSFUNCTION
725445950,5/25/2015 08:08:46,1642937403,5/25/2015 08:08:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:20:02,1642939568,5/25/2015 08:19:33,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treated,n/a,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:23:42,1642940376,5/25/2015 08:23:22,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treated,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:27:28,1642941039,5/25/2015 08:27:05,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],for,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:36:13,1642942463,5/25/2015 08:35:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:37:34,1642942730,5/25/2015 08:36:54,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treated,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:38:34,1642942892,5/25/2015 08:37:41,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:41:21,1642943337,5/25/2015 08:40:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:51:35,1642945095,5/25/2015 08:51:19,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treated,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:51:50,1642945158,5/25/2015 08:51:02,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",Exacerbation diarrhea pain patients treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 08:58:01,1642946124,5/25/2015 08:57:38,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 09:02:06,1642946694,5/25/2015 09:01:32,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treated,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 09:09:47,1642947828,5/25/2015 09:08:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 09:11:28,1642948024,5/25/2015 09:11:06,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treated,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445950,5/25/2015 09:12:49,1642948237,5/25/2015 09:12:18,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treated with,N/A,121,95,-1,138,116,TWrex-cause,803936-FS1,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID
725445951,5/25/2015 08:12:37,1642938170,5/25/2015 08:12:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:24:08,1642940508,5/25/2015 08:23:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:29:59,1642941316,5/25/2015 08:29:15,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],antimalarial,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:39:17,1642943020,5/25/2015 08:36:53,false,elite,1.0,29216801,USA,"","",172.162.14.122,[CAUSES],[CAUSES],caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:42:25,1642943503,5/25/2015 08:42:16,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],atovaquone,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:45:17,1642944031,5/25/2015 08:45:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:46:56,1642944194,5/25/2015 08:46:16,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[OTHER] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",other of [or of caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:49:04,1642944663,5/25/2015 08:48:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:54:55,1642945665,5/25/2015 08:54:45,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],and,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 08:59:02,1642946243,5/25/2015 08:58:33,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES],[CAUSES],caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 09:03:29,1642946825,5/25/2015 09:02:53,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[OTHER] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",other of other [or of of caused by,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 09:05:46,1642947238,5/25/2015 09:05:29,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 09:14:53,1642948476,5/25/2015 09:14:42,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],prevention,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 09:19:31,1642949250,5/25/2015 09:18:45,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[OTHER] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]
[OTHER]",other of other [or of of,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445951,5/25/2015 09:22:15,1642949661,5/25/2015 09:21:27,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA,N/A,225,243,1,231,264,TWrex-cause,810506-FS1,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA
725445952,5/25/2015 08:07:48,1642937165,5/25/2015 08:07:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],may be the presenting feature,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:18:55,1642939305,5/25/2015 08:18:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],presenting feature,n/a,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:22:49,1642940202,5/25/2015 08:22:37,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],may,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:25:33,1642940724,5/25/2015 08:25:01,false,elite,1.0,29216801,USA,"","",172.162.14.122,[PREVENTS],[PREVENTS],the presenting feature of,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:33:58,1642941982,5/25/2015 08:33:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],presenting feature,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:35:40,1642942382,5/25/2015 08:35:12,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:35:55,1642942440,5/25/2015 08:35:43,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],presenting,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:39:58,1642943178,5/25/2015 08:39:36,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],presenting feature,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:48:42,1642944577,5/25/2015 08:48:09,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[SYMPTOM],[SYMPTOM],presenting feature,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:50:45,1642944998,5/25/2015 08:50:34,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],presenting,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 08:56:17,1642945849,5/25/2015 08:56:00,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 09:00:48,1642946485,5/25/2015 09:00:35,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],presenting,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 09:06:52,1642947445,5/25/2015 09:06:13,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],presenting feature,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 09:10:25,1642947929,5/25/2015 09:10:11,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],presenting,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445952,5/25/2015 09:10:31,1642947933,5/25/2015 09:09:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,0,79,1,20,87,TWrex-cause,812090-FS1,DIABETIC KETOACIDOSIS may be the presenting feature of previously unrecognized DIABETES,DIABETIC KETOACIDOSIS,DIABETES
725445953,5/25/2015 11:53:14,1642987409,5/25/2015 11:52:59,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS],[PREVENTS],to prevent,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:07:51,1642990097,5/25/2015 12:07:24,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[PREVENTS],[PREVENTS],WARFARIN PULMONARY EMBOLISM,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:10:34,1642990612,5/25/2015 12:10:10,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[PREVENTS],[PREVENTS],WARFARIN to prevent subsequent PULMONARY EMBOLISM,NONE,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:13:02,1642991423,5/25/2015 12:11:51,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],anticoagulation with to prevent,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:15:20,1642992085,5/25/2015 12:15:00,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevent,n/a,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:35:29,1642996477,5/25/2015 12:35:08,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[PREVENTS],[PREVENTS],prevent thrombus formation,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:39:56,1642997362,5/25/2015 12:39:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation,n/a,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:40:19,1642997370,5/25/2015 12:39:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],WARFARIN,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:40:58,1642997466,5/25/2015 12:40:34,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with with of with,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:46:17,1642998409,5/25/2015 12:44:58,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[OTHER],[OTHER],prevent thrombus formation,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 12:57:04,1643000505,5/25/2015 12:56:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],WARFARIN to prevent PULMONARY EMBOLISM,na,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 13:01:59,1643001273,5/25/2015 13:01:33,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[PREVENTS],[PREVENTS],to prevent,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 13:02:18,1643001327,5/25/2015 13:01:40,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PREVENTS],[PREVENTS],to prevent,N/A,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 13:02:46,1643001388,5/25/2015 13:01:54,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[PREVENTS],[PREVENTS],prevent,Says prevents,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445953,5/25/2015 13:03:25,1643001510,5/25/2015 13:03:08,false,neodev,1.0,31726043,GBR,"","",5.152.201.76,[SYMPTOM],[SYMPTOM],ventricle,;;,198,144,-1,215,152,TWrex-cause,803662-FS1,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent PULMONARY EMBOLISM,PULMONARY EMBOLISM,WARFARIN
725445954,5/25/2015 09:41:13,1642952895,5/25/2015 09:41:00,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[LOCATION] [IS_A] [OTHER] [NONE],"[LOCATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:05:09,1642956673,5/25/2015 10:04:56,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [SYMPTOM] [CONTRAINDICATES] [NONE],"[TREATS]
[SYMPTOM]
[CONTRAINDICATES]
[NONE]",N/A,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:09:24,1642957225,5/25/2015 10:08:47,false,elite,1.0,29216689,USA,"","",172.164.61.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in regard to,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:11:23,1642957548,5/25/2015 10:10:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],A review on regard to,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:11:40,1642957628,5/25/2015 10:10:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50%,n/a,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:38:49,1642969969,5/25/2015 10:38:13,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],addresses disturbances,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:41:55,1642972606,5/25/2015 10:40:48,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],PV addresses complications THROMBOCYTHEMIA,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:42:54,1642973345,5/25/2015 10:42:25,false,elite,1.0,29216552,USA,"","",172.164.31.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in regard to,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:44:05,1642974003,5/25/2015 10:43:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],history of PV,n/a,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:48:07,1642975126,5/25/2015 10:47:25,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],vascular complications in patients typical of,n/a,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 10:50:20,1642975496,5/25/2015 10:50:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],circulatory disturbances typical of,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 11:26:59,1642982262,5/25/2015 11:26:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],complications in,n,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 11:41:26,1642984886,5/25/2015 11:40:38,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[MANIFESTATION],[MANIFESTATION],in regard to microvascular circulatory disturbances typical of,N/a,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 11:43:46,1642985466,5/25/2015 11:43:10,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",addresses disturbances typical of,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445954,5/25/2015 11:48:56,1642986531,5/25/2015 11:47:25,false,clixsense,1.0,31345986,GBR,"","",86.165.143.234,[CAUSES],[CAUSES],typical of,N/A,160,37,1,174,39,TWrex-cause,812771-FS1,• A review on the natural history of PV addresses the vascular complications in patients with PV in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.,THROMBOCYTHEMIA,PV
725445955,5/25/2015 09:40:32,1642952798,5/25/2015 09:39:57,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[LOCATION] [SIDE_EFFECT] [NONE],"[LOCATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:04:03,1642956511,5/25/2015 10:03:48,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [TREATS] [CONTRAINDICATES] [NONE],"[TREATS]
[CAUSES]
[CONTRAINDICATES]
[NONE]",N/A,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:07:29,1642956996,5/25/2015 10:06:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,n/a,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:07:57,1642957084,5/25/2015 10:07:39,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],the treatment of with,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:09:46,1642957319,5/25/2015 10:09:30,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:36:37,1642967821,5/25/2015 10:36:24,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:39:35,1642970687,5/25/2015 10:39:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],HEPARIN in treatment of PULMONARY EMBOLISM,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:41:30,1642972280,5/25/2015 10:41:13,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],in the treatment of patients with,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:42:34,1642973091,5/25/2015 10:42:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:44:29,1642974226,5/25/2015 10:44:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 10:46:27,1642974832,5/25/2015 10:46:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of patients,n/a,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 11:25:51,1642982081,5/25/2015 11:25:37,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 11:39:44,1642984556,5/25/2015 11:39:28,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],treatment of,N/a,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 11:42:17,1642985100,5/25/2015 11:41:59,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment of patients with,N/A,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445955,5/25/2015 11:44:28,1642985627,5/25/2015 11:43:50,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,[OTHER],[OTHER],treatment,n/a,74,32,-1,91,39,TWrex-cause,803544-FS1,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN
725445956,5/25/2015 08:07:28,1642937119,5/25/2015 08:07:17,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment of,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:18:29,1642939223,5/25/2015 08:18:15,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],with,n/a,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:22:35,1642940175,5/25/2015 08:22:22,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:25:00,1642940667,5/25/2015 08:24:26,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],Treatment of with,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:33:39,1642941915,5/25/2015 08:33:17,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment of,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:35:09,1642942239,5/25/2015 08:34:06,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:35:40,1642942381,5/25/2015 08:35:26,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:39:30,1642943104,5/25/2015 08:39:11,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment of,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:48:05,1642944410,5/25/2015 08:47:34,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],Treatment with,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:50:31,1642944966,5/25/2015 08:50:19,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],Treatment,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 08:55:58,1642945763,5/25/2015 08:55:41,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 09:00:32,1642946398,5/25/2015 09:00:19,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],Treatment,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 09:06:10,1642947329,5/25/2015 09:05:30,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 09:09:53,1642947850,5/25/2015 09:09:18,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445956,5/25/2015 09:10:08,1642947904,5/25/2015 09:09:47,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],Treatment,N/A,33,61,-1,54,81,TWrex-cause,803426-FS1,"Farr PM, Shuster S. Treatment of SEBORRHOEIC DERMATITIS with TOPICAL KETOCONAZOLE",SEBORRHOEIC DERMATITIS,TOPICAL KETOCONAZOLE
725445957,5/25/2015 09:17:25,1642948922,5/25/2015 09:17:04,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],controlled,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:26:16,1642950240,5/25/2015 09:25:58,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],placebo controlled trial of,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:27:00,1642950413,5/25/2015 09:26:25,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:31:27,1642951137,5/25/2015 09:31:09,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[SYMPTOM] [NONE] [IS_A] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]
[IS_A]
[NONE]",N/A,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:34:20,1642951715,5/25/2015 09:33:59,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],controlled trial,n/a,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:34:47,1642951827,5/25/2015 09:32:46,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],controlled trial of ABCIXIMAB before and during coronary intervention,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:47:19,1642953728,5/25/2015 09:46:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,n/a,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:54:28,1642954721,5/25/2015 09:53:59,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[PREVENTS],[PREVENTS],coronary intervention,n/a,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:55:59,1642955028,5/25/2015 09:55:33,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CONTRAINDICATES] [NONE],"[CONTRAINDICATES]
[NONE]",5620YGZW,5620YGZW,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:56:30,1642955155,5/25/2015 09:55:49,false,elite,1.0,29216689,USA,"","",172.164.61.103,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",during,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 09:59:30,1642955818,5/25/2015 09:59:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],intervention in,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 10:26:18,1642961317,5/25/2015 10:26:05,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],intervention,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 10:26:31,1642961434,5/25/2015 10:25:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],trial of ABCIXIMAB in REFRACTORY UNSTABLE ANGINA:,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 10:31:13,1642963625,5/25/2015 10:30:01,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",controlled trial of before and during coronary intervention in,N/A,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445957,5/25/2015 10:31:24,1642963771,5/25/2015 10:30:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],trial of in,n/a,92,39,-1,117,48,TWrex-cause,800959-FS1,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB
725445958,5/25/2015 10:47:29,1642975049,5/25/2015 10:46:53,false,elite,1.0,29216552,USA,"","",172.164.31.187,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",symptoms such as:,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 11:30:51,1642982920,5/25/2015 11:30:33,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],symptoms,n,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 11:45:57,1642985853,5/25/2015 11:45:25,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[SYMPTOM],[SYMPTOM],symptoms may herald the onset of,N/a,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 11:48:51,1642986497,5/25/2015 11:48:11,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",symptoms such as:,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:03:01,1642989133,5/25/2015 12:02:29,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[SYMPTOM],[SYMPTOM],RECURRENT TTP CONFUSION,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:04:37,1642989421,5/25/2015 12:03:46,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],symptoms herald onset,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:07:14,1642989951,5/25/2015 12:06:49,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[SYMPTOM],[SYMPTOM],symptoms may onset RECURRENT TTP such CONFUSION,NONE,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:12:16,1642991133,5/25/2015 12:11:46,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[SYMPTOM],[SYMPTOM],may herald,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:12:59,1642991414,5/25/2015 12:12:38,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],onset,n/a,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:28:27,1642994880,5/25/2015 12:28:03,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP,n/a,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:32:23,1642995691,5/25/2015 12:32:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],RECURRENT TTP,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:36:56,1642996761,5/25/2015 12:36:30,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",symptoms of symptoms,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:37:03,1642996799,5/25/2015 12:36:07,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],systemic symptoms may herald the onset of,N/A,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:47:15,1642998603,5/25/2015 12:46:58,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445958,5/25/2015 12:47:49,1642998706,5/25/2015 12:46:50,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[MANIFESTATION],[MANIFESTATION],herald the onset,n/a,145,109,1,153,122,TWrex-cause,813078-FS1,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of RECURRENT TTP such as: ◊ Weakness ◊ CONFUSION ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,CONFUSION,RECURRENT TTP
725445959,5/25/2015 09:18:18,1642949071,5/25/2015 09:18:04,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],low,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:27:01,1642950411,5/25/2015 09:26:31,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[PART_OF],[PART_OF],Clinical Manifestations of,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:28:33,1642950719,5/25/2015 09:27:44,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [OTHER],"[PART_OF]
[OTHER]",of other of part of,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:31:58,1642951226,5/25/2015 09:31:47,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [ASSOCIATED_WITH] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:35:03,1642951859,5/25/2015 09:34:34,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Manifestations,n/a,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:35:37,1642952015,5/25/2015 09:35:20,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[MANIFESTATION],[MANIFESTATION],Manifestations,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:49:35,1642954064,5/25/2015 09:48:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [LOCATION],"[LOCATION]
[MANIFESTATION]",Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME] COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,n/a,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:57:12,1642955253,5/25/2015 09:56:15,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[NONE] [PREVENTS] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 09:58:22,1642955544,5/25/2015 09:57:16,false,elite,1.0,29216689,USA,"","",172.164.61.103,[IS_A],[IS_A],of,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:00:53,1642955930,5/25/2015 10:00:08,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",are present,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:27:35,1642961827,5/25/2015 10:26:44,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[ASSOCIATED_WITH] [CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",Manifestations,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:27:57,1642961958,5/25/2015 10:26:59,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],STAPHYLOCOCCAL TOXIC SHOCK SYNDROME] COAGULASE NEGATIVE STAPHYLOCOCCI,N/A,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:33:01,1642964830,5/25/2015 10:32:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's no link between the terms.,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:33:07,1642964879,5/25/2015 10:31:49,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],present,n/a,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445959,5/25/2015 10:36:44,1642967877,5/25/2015 10:33:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,these are normal,27,65,1,61,97,TWrex-cause,812023-FS1,Clinical Manifestations of STAPHYLOCOCCAL TOXIC SHOCK SYNDROME]  COAGULASE NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,COAGULASE NEGATIVE STAPHYLOCOCCI
725445960,5/25/2015 10:40:23,1642971340,5/25/2015 10:39:39,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for patients with STERILE HEMATURIA or BLADDER CANCER,N/A,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 10:44:02,1642973978,5/25/2015 10:43:08,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,Both of them are symptoms of something else,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 10:44:05,1642974008,5/25/2015 10:43:34,false,elite,1.0,29216552,USA,"","",172.164.31.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],may be indicated,N/A,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 10:45:46,1642974727,5/25/2015 10:44:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(eg, for patients with",n/a,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 10:49:37,1642975354,5/25/2015 10:49:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 10:51:13,1642975578,5/25/2015 10:50:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],"specific instances (eg,",N/A,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 11:27:40,1642982372,5/25/2015 11:27:18,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],may be indicated,n,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 11:42:16,1642985087,5/25/2015 11:41:52,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/a,Unrelated terms,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 11:45:13,1642985723,5/25/2015 11:44:20,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,"Related, but not express by terms above.",123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 11:53:47,1642987456,5/25/2015 11:51:52,false,clixsense,1.0,31345986,GBR,"","",86.165.143.234,[NONE],[NONE],N/A,These are 2 conditions that are tested for using the same techniques,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 11:55:24,1642987723,5/25/2015 11:54:54,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[SYMPTOM],[SYMPTOM],STERILE HEMATURIA BLADDER CANCER,N/A,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 12:04:00,1642989322,5/25/2015 12:03:27,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Other tests specific instances high risk of BLADDER CANCER,NONE,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 12:09:17,1642990379,5/25/2015 12:08:24,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[NONE],[NONE],N/A,"NO CONNECTION, JUST INSTANCES OF DISEASE WHERE TESTS ARE OR ARE NOT APPROPRIATE",123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 12:10:50,1642990628,5/25/2015 12:10:33,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445960,5/25/2015 12:24:20,1642994032,5/25/2015 12:23:58,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Other tests (eg, urine cytology, cystoscopy, bladder biopsy)",n/a,123,194,1,139,208,TWrex-cause,813355-FS1,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with STERILE HEMATURIA suprapubic or perineal discomfort, or a high risk of BLADDER CANCER",STERILE HEMATURIA,BLADDER CANCER
725445961,5/25/2015 09:05:39,1642947224,5/25/2015 09:05:12,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[OTHER] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",Other treatment of caused by,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:06:50,1642947410,5/25/2015 09:06:34,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:15:38,1642948625,5/25/2015 09:15:24,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:22:11,1642949654,5/25/2015 09:21:27,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[OTHER] [TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]
[OTHER]",Other treatment of caused by,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:24:17,1642949890,5/25/2015 09:24:03,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by susceptible,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:25:48,1642950078,5/25/2015 09:24:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by susceptible SALMONELLA TYPHI,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:27:48,1642950617,5/25/2015 09:27:27,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[TREATS] [NONE],"[TREATS]
[NONE]",N/A,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:31:55,1642951195,5/25/2015 09:31:39,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:40:23,1642952767,5/25/2015 09:39:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Typhoid Fever and Other Salmonella Infections Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible SALMONELLA TYPHI,n/a,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:42:35,1642953103,5/25/2015 09:42:26,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:50:58,1642954284,5/25/2015 09:49:55,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[CAUSES] [PART_OF] [OTHER] [NONE],"[CAUSES]
[PART_OF]
[OTHER]
[NONE]",no,bo,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:52:00,1642954445,5/25/2015 09:51:22,false,neodev,1.0,32350671,USA,DE,Wilmington,162.223.94.90,[CAUSES],[CAUSES],caused by,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:53:36,1642954641,5/25/2015 09:53:21,false,elite,1.0,29216689,USA,"","",172.164.61.103,[CAUSES],[CAUSES],caused by,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:53:43,1642954645,5/25/2015 09:53:25,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445961,5/25/2015 09:57:44,1642955417,5/25/2015 09:54:53,false,prodege,1.0,32672123,USA,CA,Irvine,192.171.229.225,[CAUSES],[CAUSES],caused by,N/A,79,132,1,107,148,TWrex-cause,811574-FS1,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI
725445962,5/25/2015 09:28:24,1642950693,5/25/2015 09:28:09,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],initial treatment,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 09:36:17,1642952142,5/25/2015 09:36:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 09:37:05,1642952229,5/25/2015 09:36:52,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[SYMPTOM] [SIDE_EFFECT] [NONE] [OTHER],"[SYMPTOM]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 09:56:07,1642955056,5/25/2015 09:54:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",n/a,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 09:59:29,1642955796,5/25/2015 09:59:18,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [TREATS] [NONE] [IS_A],"[TREATS]
[CAUSES]
[IS_A]
[NONE]",N/A,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:01:14,1642956025,5/25/2015 10:00:36,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],treatment of,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:03:48,1642956476,5/25/2015 10:03:22,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:30:25,1642963174,5/25/2015 10:29:55,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:31:09,1642963580,5/25/2015 10:30:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],AMPHOTERICIN B initial treatment of PRESUMPTIVE BLASTOMYCOSIS,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:35:51,1642967041,5/25/2015 10:35:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],for initial treatment,n/a,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:36:56,1642968124,5/25/2015 10:36:26,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],treatment of,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:37:23,1642968530,5/25/2015 10:36:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 10:40:13,1642971218,5/25/2015 10:39:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],is preferred for initial treatment of,n/a,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 11:20:15,1642980850,5/25/2015 11:19:57,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],initial treatment,n,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445962,5/25/2015 11:35:54,1642983951,5/25/2015 11:35:29,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],initial treatment of,N/a,272,43,-1,296,57,TWrex-cause,800204-FS1,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B
725445963,5/25/2015 09:28:36,1642950721,5/25/2015 09:28:26,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[PREVENTS],[PREVENTS],greatly reduced with,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 09:36:33,1642952177,5/25/2015 09:36:18,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],reduced,n/a,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 09:37:26,1642952317,5/25/2015 09:37:07,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[CAUSES] [CONTRAINDICATES] [ASSOCIATED_WITH] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 09:57:06,1642955249,5/25/2015 09:56:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,n/a,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 09:59:45,1642955851,5/25/2015 09:59:31,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [TREATS] [SIDE_EFFECT] [NONE],"[TREATS]
[LOCATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:01:34,1642956130,5/25/2015 10:01:16,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced with,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:04:24,1642956581,5/25/2015 10:03:50,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",can be reduced with,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:31:23,1642963767,5/25/2015 10:30:26,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],greatly reduced,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:31:53,1642964111,5/25/2015 10:31:11,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],risk for STROKE reduced with WARFARIN,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:36:12,1642967393,5/25/2015 10:35:52,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],can be greatly reduced,n/a,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:37:21,1642968525,5/25/2015 10:36:58,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",can be greatly reduced with,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:37:54,1642969050,5/25/2015 10:37:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],greatly reduced with,N/A,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 10:41:25,1642972214,5/25/2015 10:40:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],risk can be greatly reduced,n/a,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 11:20:32,1642980929,5/25/2015 11:20:17,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],greatly reduced,n,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445963,5/25/2015 11:36:21,1642984069,5/25/2015 11:35:55,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],The risk for can be greatly reduced with,N/a,25,80,-1,30,88,TWrex-cause,803834-FS1,COMMENTARY  The risk for STROKE in patients with AF can be greatly reduced with WARFARIN,STROKE,WARFARIN
725445964,5/25/2015 09:40:59,1642952865,5/25/2015 09:40:47,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[LOCATION] [PART_OF] [OTHER] [NONE],"[LOCATION]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:04:54,1642956638,5/25/2015 10:04:39,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [SYMPTOM] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[NONE]",N/A,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:08:45,1642957181,5/25/2015 10:08:29,false,elite,1.0,29216689,USA,"","",172.164.61.103,[CAUSES],[CAUSES],caused by,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:10:03,1642957354,5/25/2015 10:08:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES],"[TREATS]
[CAUSES]","Other Complicated Vulvovaginal Infections Intravaginal: CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by CANDIDA other than C. albicans , or occurring in women with underlying medical conditions.",n/a,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:10:41,1642957412,5/25/2015 10:10:20,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:38:12,1642969340,5/25/2015 10:37:19,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],caused,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:40:47,1642971735,5/25/2015 10:40:15,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],VULVOVAGINAL CANDIDIASIS caused by CANDIDA,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:42:23,1642972933,5/25/2015 10:42:01,false,elite,1.0,29216552,USA,"","",172.164.31.187,[CAUSES],[CAUSES],caused by,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:43:36,1642973788,5/25/2015 10:43:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:45:54,1642974741,5/25/2015 10:45:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 10:47:24,1642975024,5/25/2015 10:46:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 11:26:35,1642982213,5/25/2015 11:26:19,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 11:40:32,1642984741,5/25/2015 11:40:12,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],caused by,N/a,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 11:43:09,1642985367,5/25/2015 11:42:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445964,5/25/2015 11:47:23,1642986124,5/25/2015 11:46:18,false,clixsense,1.0,31345986,GBR,"","",86.165.143.234,[SYMPTOM],[SYMPTOM],caused,N/A,149,201,1,172,208,TWrex-cause,812304-FS1,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA
725445965,5/25/2015 08:09:18,1642937555,5/25/2015 08:09:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:20:32,1642939720,5/25/2015 08:20:15,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],Treatment,n/a,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:24:21,1642940582,5/25/2015 08:24:07,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:30:03,1642941319,5/25/2015 08:29:18,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:38:06,1642942818,5/25/2015 08:37:42,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:38:44,1642942917,5/25/2015 08:37:57,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:40:00,1642943186,5/25/2015 08:39:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",Treatment of,v,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:42:34,1642943533,5/25/2015 08:42:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:52:16,1642945231,5/25/2015 08:51:58,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:53:06,1642945408,5/25/2015 08:52:22,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 08:58:51,1642946227,5/25/2015 08:58:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 09:02:57,1642946760,5/25/2015 09:02:36,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 09:11:40,1642948042,5/25/2015 09:11:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 09:12:01,1642948140,5/25/2015 09:11:46,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],Treatment,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445965,5/25/2015 09:14:11,1642948427,5/25/2015 09:13:39,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",Treatment of,N/A,39,72,-1,51,84,TWrex-cause,803836-FS1,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN
725445966,5/25/2015 09:17:02,1642948856,5/25/2015 09:16:45,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trials,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:25:56,1642950118,5/25/2015 09:25:46,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],due to,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:26:21,1642950270,5/25/2015 09:25:39,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [IS_A] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with with A of,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:31:08,1642951093,5/25/2015 09:30:57,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[SYMPTOM] [NONE] [OTHER] [PART_OF],"[SYMPTOM]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:32:44,1642951397,5/25/2015 09:30:48,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7],N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:33:58,1642951657,5/25/2015 09:33:45,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],due to,n/a,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:46:13,1642953536,5/25/2015 09:44:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"Antimotility agents Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7] A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",n/a,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:53:56,1642954653,5/25/2015 09:53:34,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[SYMPTOM],[SYMPTOM],due to,n/a,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:55:31,1642954972,5/25/2015 09:55:15,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [SYMPTOM] [OTHER] [NONE],"[PREVENTS]
[SYMPTOM]
[OTHER]
[NONE]",N/A,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:55:48,1642955009,5/25/2015 09:55:28,false,elite,1.0,29216689,USA,"","",172.164.61.103,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",due to,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 09:59:00,1642955673,5/25/2015 09:58:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",due to,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 10:25:36,1642961095,5/25/2015 10:25:00,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],TRAVELER'S DIARRHEA due ENTEROTOXIGENIC E COLI[7],N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 10:26:03,1642961235,5/25/2015 10:25:14,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[ASSOCIATED_WITH],[ASSOCIATED_WITH],due to,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 10:29:57,1642962874,5/25/2015 10:27:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],due to,N/A,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445966,5/25/2015 10:30:41,1642963297,5/25/2015 10:30:21,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],due to,n/a,113,140,1,131,162,TWrex-cause,810766-FS1,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI
725445967,5/25/2015 08:10:18,1642937772,5/25/2015 08:10:05,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:22:03,1642940015,5/25/2015 08:21:48,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:25:08,1642940681,5/25/2015 08:24:54,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:34:17,1642942027,5/25/2015 08:34:02,false,elite,1.0,29216801,USA,"","",172.162.14.122,[CAUSES],[CAUSES],caused by,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:39:55,1642943158,5/25/2015 08:39:43,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:41:08,1642943328,5/25/2015 08:40:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:42:42,1642943578,5/25/2015 08:42:02,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by or drug.,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:44:24,1642943816,5/25/2015 08:44:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:53:11,1642945435,5/25/2015 08:52:57,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 08:55:01,1642945670,5/25/2015 08:54:28,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES],[CAUSES],caused by,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 09:00:10,1642946386,5/25/2015 08:59:44,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by or drug.,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 09:03:54,1642946862,5/25/2015 09:03:40,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 09:12:58,1642948249,5/25/2015 09:12:41,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 09:15:15,1642948527,5/25/2015 09:14:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445967,5/25/2015 09:15:25,1642948551,5/25/2015 09:14:45,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],caused by,n/a,80,94,1,81,120,TWrex-cause,810529-FS1,"100 ,   124 ,   126 ,   d ,   e  First line agent for treatment of all forms of TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to the drug.",TB,MYCOBACTERIUM TUBERCULOSIS
725445968,5/25/2015 09:40:44,1642952830,5/25/2015 09:40:34,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [ASSOCIATED_WITH] [MANIFESTATION] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:04:38,1642956605,5/25/2015 10:04:07,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [MANIFESTATION] [SIDE_EFFECT] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[MANIFESTATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:08:27,1642957137,5/25/2015 10:07:59,false,elite,1.0,29216689,USA,"","",172.164.61.103,[SIDE_EFFECT] [MANIFESTATION],"[MANIFESTATION]
[SIDE_EFFECT]",reflect,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:08:38,1642957156,5/25/2015 10:07:30,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]","Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",n/a,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:10:17,1642957361,5/25/2015 10:09:48,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],due to,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:37:17,1642968431,5/25/2015 10:36:42,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],reflect,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:40:14,1642971230,5/25/2015 10:39:36,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],symptoms in CML reflect SPLENOMEGALY,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:42:00,1642972666,5/25/2015 10:41:32,false,elite,1.0,29216552,USA,"","",172.164.31.187,[SYMPTOM],[SYMPTOM],symptoms in reflect,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:43:15,1642973600,5/25/2015 10:42:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],symptoms in,n/a,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:45:10,1642974560,5/25/2015 10:44:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],symptoms in,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 10:46:54,1642974931,5/25/2015 10:46:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],symptoms,n/a,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 11:26:18,1642982187,5/25/2015 11:25:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],reflect,n,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 11:40:10,1642984668,5/25/2015 11:39:45,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[SYMPTOM],[SYMPTOM],constitutional symptoms in,N/a,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 11:42:55,1642985277,5/25/2015 11:42:18,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",symptoms reflect,N/A,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445968,5/25/2015 11:45:59,1642985854,5/25/2015 11:44:30,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[SYMPTOM],[SYMPTOM],symptoms,n/a,108,41,1,119,44,TWrex-cause,812709-FS1,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",SPLENOMEGALY,CML
725445969,5/25/2015 08:11:28,1642938044,5/25/2015 08:10:56,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],is present.,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:22:53,1642940240,5/25/2015 08:22:33,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:26:33,1642940887,5/25/2015 08:26:08,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],hepatorenal,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:35:14,1642942294,5/25/2015 08:34:56,false,elite,1.0,29216801,USA,"","",172.162.14.122,[OTHER],[OTHER],or even,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:41:03,1642943317,5/25/2015 08:40:52,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:42:54,1642943602,5/25/2015 08:42:38,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],is present.,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:44:46,1642943892,5/25/2015 08:44:05,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with or is,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:46:28,1642944161,5/25/2015 08:45:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],(often present.,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:54:09,1642945535,5/25/2015 08:53:56,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],hepatorenal,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 08:57:10,1642945965,5/25/2015 08:56:26,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[SYMPTOM],[SYMPTOM],present.,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 09:01:33,1642946606,5/25/2015 09:01:05,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with is,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 09:04:46,1642947046,5/25/2015 09:04:32,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],"syndrome,",N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 09:14:09,1642948426,5/25/2015 09:13:55,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],upper,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 09:17:25,1642948920,5/25/2015 09:16:45,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with or is,N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445969,5/25/2015 09:21:25,1642949567,5/25/2015 09:19:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA",N/A,84,155,1,90,179,TWrex-cause,814293-FS1,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA
725445970,5/25/2015 09:07:42,1642947556,5/25/2015 09:07:24,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[LOCATION],[LOCATION],be,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:16:29,1642948789,5/25/2015 09:16:15,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],prevent,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:24:35,1642949928,5/25/2015 09:23:27,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],in,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:25:19,1642950012,5/25/2015 09:24:56,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[LOCATION],[LOCATION],accumulation in BONE resulting in,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:30:16,1642950928,5/25/2015 09:29:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],resulting in SEVERE OSTEOMALACIA,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:30:36,1642951013,5/25/2015 09:29:50,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[TREATS] [NONE],"[TREATS]
[NONE]",N/A,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:33:10,1642951529,5/25/2015 09:32:50,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],accumulation,n/a,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:43:35,1642953207,5/25/2015 09:42:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CONTRAINDICATES] [LOCATION],"[LOCATION]
[CONTRAINDICATES]","Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",n/a,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:53:15,1642954604,5/25/2015 09:52:49,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[PREVENTS],[PREVENTS],resulting,n/a,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:54:49,1642954806,5/25/2015 09:54:20,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE] [OTHER],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]
[NONE]",N/A,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:55:00,1642954814,5/25/2015 09:54:31,false,elite,1.0,29216689,USA,"","",172.164.61.103,[MANIFESTATION],[MANIFESTATION],resulting in,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 09:57:22,1642955296,5/25/2015 09:56:39,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 10:23:39,1642960342,5/25/2015 10:22:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[MANIFESTATION],[MANIFESTATION],BONE resulting in SEVERE OSTEOMALACIA,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 10:24:39,1642960741,5/25/2015 10:24:16,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],resulting,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445970,5/25/2015 10:25:09,1642960937,5/25/2015 10:23:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],accumulation in resulting in,N/A,146,164,-1,149,183,TWrex-cause,802592-FS1,"Aluminum containing compounds should be avoided in renal failure, especially in patients receiving long term dialysis, to prevent accumulation in BONE resulting in SEVERE OSTEOMALACIA",BONE,SEVERE OSTEOMALACIA
725445971,5/25/2015 11:53:35,1642987433,5/25/2015 11:53:15,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",is always followed by,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:08:18,1642990179,5/25/2015 12:07:54,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[CAUSES],[CAUSES],MIGRAINE HEADACHE,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:10:57,1642990689,5/25/2015 12:10:36,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MIGRAINE occurs throbbing HEADACHE,NONE,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:13:48,1642991668,5/25/2015 12:13:05,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],always followed by,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:15:47,1642992199,5/25/2015 12:15:28,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],followed by,n/a,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:35:58,1642996518,5/25/2015 12:35:31,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[IS_A],[IS_A],followed by,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:40:30,1642997417,5/25/2015 12:39:56,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],always followed by a throbbing HEADACHE frequently with vomiting.,n/a,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:41:13,1642997525,5/25/2015 12:40:27,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],throbbing HEADACHE,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:42:11,1642997711,5/25/2015 12:41:02,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",is by a with,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:46:51,1642998514,5/25/2015 12:46:18,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],always followed by,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 12:57:50,1643000622,5/25/2015 12:57:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],MIGRAINE followed by HEADACHE,na,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 13:02:59,1643001409,5/25/2015 13:02:02,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",occurs and is always followed by,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 13:03:00,1643001410,5/25/2015 13:02:14,false,neodev,1.0,31726043,GBR,"","",5.152.201.76,[LOCATION],[LOCATION],"ataxia,",''',211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 13:03:24,1643001503,5/25/2015 13:02:48,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],followed by,Says it is followed by,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445971,5/25/2015 13:03:24,1643001508,5/25/2015 13:02:32,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[MANIFESTATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",occurs and is always followed by a throbbing,N/A,211,10,1,218,18,TWrex-cause,813482-FS1,"66   This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE frequently with vomiting.",HEADACHE,MIGRAINE
725445972,5/25/2015 08:05:23,1642936768,5/25/2015 08:04:24,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],to treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:16:31,1642938877,5/25/2015 08:16:15,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:21:10,1642939837,5/25/2015 08:20:57,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:21:40,1642939950,5/25/2015 08:21:06,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:21:41,1642939956,5/25/2015 08:21:24,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],to treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:25:19,1642940694,5/25/2015 08:25:01,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],treat,n/a,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:25:26,1642940722,5/25/2015 08:24:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:25:53,1642940794,5/25/2015 08:25:26,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",drug with treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:34:16,1642942026,5/25/2015 08:34:05,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:36:04,1642942450,5/25/2015 08:35:47,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:41:23,1642943338,5/25/2015 08:40:27,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:48:55,1642944610,5/25/2015 08:48:44,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:53:17,1642945444,5/25/2015 08:52:59,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",DRUG drug with treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 08:59:04,1642946244,5/25/2015 08:58:52,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],therapy,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445972,5/25/2015 09:00:25,1642946396,5/25/2015 08:59:21,false,neodev,1.0,32350671,USA,DE,Wilmington,162.223.94.90,[TREATS],[TREATS],treat,N/A,77,55,-1,93,67,TWrex-cause,803322-FS1,DRUG THERAPY  Introduction  Consider drug therapy with METHOTREXATE to treat ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
725445973,5/25/2015 08:12:21,1642938148,5/25/2015 08:11:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],use in patients with severe,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:23:44,1642940388,5/25/2015 08:23:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],use in,n/a,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:28:25,1642941106,5/25/2015 08:27:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],severe,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:36:35,1642942483,5/25/2015 08:36:01,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],use in with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:42:08,1642943414,5/25/2015 08:41:50,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:45:01,1642943961,5/25/2015 08:43:49,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],use,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:46:05,1642944128,5/25/2015 08:45:27,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:48:43,1642944575,5/25/2015 08:48:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],use in patients with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:54:42,1642945632,5/25/2015 08:54:27,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],prophylactic,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 08:58:33,1642946199,5/25/2015 08:58:07,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],use in patients,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 09:02:45,1642946737,5/25/2015 09:02:19,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 09:05:23,1642947156,5/25/2015 09:05:08,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 09:14:40,1642948461,5/25/2015 09:14:26,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],safety analysis,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 09:18:42,1642949114,5/25/2015 09:18:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445973,5/25/2015 09:19:49,1642949301,5/25/2015 09:18:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],use patients with,N/A,162,68,-1,167,96,TWrex-cause,803685-FS1,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA
725445974,5/25/2015 09:39:40,1642952682,5/25/2015 09:39:28,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PART_OF] [ASSOCIATED_WITH] [SYMPTOM] [CAUSES] [NONE],"[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:03:20,1642956362,5/25/2015 10:03:01,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [SIDE_EFFECT] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:05:42,1642956752,5/25/2015 10:04:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"KRABBE'S DISEASE KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",n/a,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:06:14,1642956858,5/25/2015 10:05:26,false,elite,1.0,29216689,USA,"","",172.164.61.103,[IS_A],[IS_A],is a that,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:08:09,1642957099,5/25/2015 10:07:42,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],causes,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:35:33,1642966798,5/25/2015 10:35:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],causes,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:38:17,1642969414,5/25/2015 10:37:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],KRABBE'S DISEASE causes BLINDNESS,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:40:46,1642971718,5/25/2015 10:40:30,false,elite,1.0,29216552,USA,"","",172.164.31.187,[CAUSES],[CAUSES],that causes,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:41:22,1642972174,5/25/2015 10:40:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],causes,n/a,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:43:30,1642973738,5/25/2015 10:43:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 10:45:11,1642974558,5/25/2015 10:44:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes,n/a,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 11:24:18,1642981782,5/25/2015 11:23:54,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],that causes,n,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 11:39:01,1642984443,5/25/2015 11:38:40,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],that causes,N/a,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 11:41:22,1642984884,5/25/2015 11:40:36,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],that causes,N/A,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445974,5/25/2015 11:46:40,1642986010,5/25/2015 11:46:00,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[SIDE_EFFECT],[SIDE_EFFECT],causes,n/a,93,0,1,101,16,TWrex-cause,814972-FS1,"KRABBE'S DISEASE  KRABBE'S DISEASE is a sphingolipidosis that causes retardation, paralysis, BLINDNESS deafness, and pseudobulbar palsy, progressing to death.",BLINDNESS,KRABBE'S DISEASE
725445975,5/25/2015 08:09:01,1642937473,5/25/2015 08:08:47,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment with,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:20:14,1642939652,5/25/2015 08:20:02,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:24:05,1642940498,5/25/2015 08:23:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:28:25,1642941108,5/25/2015 08:27:31,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],treatment with for,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:37:35,1642942751,5/25/2015 08:36:27,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:37:54,1642942791,5/25/2015 08:37:41,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:39:17,1642943021,5/25/2015 08:38:41,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,v,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:42:00,1642943400,5/25/2015 08:41:33,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment with,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:51:51,1642945184,5/25/2015 08:51:37,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:52:21,1642945269,5/25/2015 08:51:51,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 08:58:29,1642946183,5/25/2015 08:58:06,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 09:02:28,1642946718,5/25/2015 09:02:10,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 09:11:02,1642948001,5/25/2015 09:09:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment with INTERFERON for CHRONIC HEPATITIS C,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 09:11:44,1642948096,5/25/2015 09:11:30,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445975,5/25/2015 09:13:36,1642948329,5/25/2015 09:12:55,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,N/A,158,143,-1,176,153,TWrex-cause,800452-FS1,"Evidence: • In large cohort studies, survival and complication free survival were significantly better in patients who received treatment with INTERFERON for CHRONIC HEPATITIS C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",CHRONIC HEPATITIS C,INTERFERON
725445976,5/25/2015 08:05:47,1642936835,5/25/2015 08:05:26,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],through,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:16:52,1642938931,5/25/2015 08:16:32,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],protrudes through,n/a,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:21:24,1642939871,5/25/2015 08:21:12,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],containing,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:22:20,1642940071,5/25/2015 08:21:44,false,elite,1.0,29216801,USA,"","",172.162.14.122,[MANIFESTATION],[MANIFESTATION],protrudes through the,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:25:45,1642940770,5/25/2015 08:25:20,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],in which,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:26:01,1642940813,5/25/2015 08:25:27,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],protrudes through the SPINE,n/a,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:26:37,1642940890,5/25/2015 08:25:57,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:27:26,1642941005,5/25/2015 08:25:38,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],through the,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:34:30,1642942086,5/25/2015 08:34:18,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],spinal,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:36:52,1642942581,5/25/2015 08:36:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],protrudes through SPINE,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:43:38,1642943744,5/25/2015 08:42:36,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES] [LOCATION] [SYMPTOM],"[CAUSES]
[LOCATION]
[SYMPTOM]",spinal cord surrounding membranes protrudes through SPINE,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:49:12,1642944727,5/25/2015 08:49:01,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[LOCATION],[LOCATION],surrounding,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:53:39,1642945484,5/25/2015 08:53:20,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],a,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 08:59:18,1642946254,5/25/2015 08:59:05,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],fluid,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445976,5/25/2015 09:02:07,1642946695,5/25/2015 09:00:29,false,neodev,1.0,32350671,USA,DE,Wilmington,162.223.94.90,[CAUSES],[CAUSES],through,N/A,265,149,-1,269,165,TWrex-cause,802113-FS1,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] SPINAL DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the SPINE",SPINE,SPINAL DEFORMITY
725445977,5/25/2015 08:06:03,1642936859,5/25/2015 08:05:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],short course treatment of,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:17:06,1642938962,5/25/2015 08:16:53,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:21:38,1642939911,5/25/2015 08:21:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:22:39,1642940178,5/25/2015 08:22:22,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],treatment of,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:26:04,1642940814,5/25/2015 08:25:49,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:26:44,1642940911,5/25/2015 08:26:03,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],short course treatment,n/a,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:27:22,1642940997,5/25/2015 08:26:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]","A, treatment of a",N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:28:28,1642941115,5/25/2015 08:27:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:34:43,1642942114,5/25/2015 08:34:31,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:37:21,1642942725,5/25/2015 08:36:57,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:44:13,1642943804,5/25/2015 08:43:40,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],short course treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:49:28,1642944745,5/25/2015 08:49:14,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:54:10,1642945531,5/25/2015 08:53:42,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 08:59:33,1642946268,5/25/2015 08:59:19,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445977,5/25/2015 09:01:31,1642946603,5/25/2015 09:00:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,152,95,-1,175,122,TWrex-cause,800453-FS1,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as LONG ACTING CHLORAMPHENICOL in short course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a randomised non inferiority study.",MENINGOCOCCAL MENINGITIS,LONG ACTING CHLORAMPHENICOL
725445978,5/25/2015 09:05:09,1642947105,5/25/2015 09:04:44,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:06:33,1642947378,5/25/2015 09:06:16,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],assessment,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:15:22,1642948538,5/25/2015 09:15:11,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],from,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:21:22,1642949561,5/25/2015 09:20:52,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:24:02,1642949854,5/25/2015 09:23:45,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:24:41,1642949938,5/25/2015 09:23:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],clinical assessment of high users,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:27:25,1642950526,5/25/2015 09:24:41,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",N/A,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:31:38,1642951160,5/25/2015 09:31:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:39:19,1642952646,5/25/2015 09:38:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.,n/a,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:42:24,1642953077,5/25/2015 09:42:10,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],clinical assessment,-,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:49:53,1642954119,5/25/2015 09:49:17,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[NONE] [SIDE_EFFECT] [SYMPTOM],"[SYMPTOM]
[SIDE_EFFECT]
[NONE]",no,no,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:51:20,1642954328,5/25/2015 09:48:26,false,neodev,1.0,32350671,USA,DE,Wilmington,162.223.94.90,[OTHER],[OTHER],clinical assessment of high users,the two terms are both treatments,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:53:19,1642954605,5/25/2015 09:52:40,false,elite,1.0,29216689,USA,"","",172.164.61.103,[OTHER],[OTHER],and,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:53:22,1642954607,5/25/2015 09:52:04,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",N/A,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445978,5/25/2015 09:55:44,1642955007,5/25/2015 09:54:49,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",users from,N/A,75,46,1,95,70,TWrex-cause,810496-FS1,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS
725445979,5/25/2015 09:27:52,1642950619,5/25/2015 09:27:34,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],have been studied,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:30:49,1642951036,5/25/2015 09:30:17,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH],[ASSOCIATED_WITH],without,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:32:51,1642951415,5/25/2015 09:32:39,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[ASSOCIATED_WITH] [NONE] [OTHER],"[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:35:49,1642952032,5/25/2015 09:35:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],studied,n/a,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:53:11,1642954603,5/25/2015 09:52:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]","Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",n/a,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:59:02,1642955675,5/25/2015 09:58:34,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [TREATS] [NONE] [PART_OF],"[TREATS]
[LOCATION]
[PART_OF]
[NONE]",N/A,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 09:59:54,1642955857,5/25/2015 09:59:35,false,elite,1.0,29216689,USA,"","",172.164.61.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],have been studied in,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:02:42,1642956279,5/25/2015 10:02:17,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],have been studied,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:29:05,1642962521,5/25/2015 10:28:26,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],"studied without significant clinical benefit,",N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:29:52,1642962846,5/25/2015 10:29:17,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:34:44,1642966106,5/25/2015 10:34:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],"have been studied without significant benefit,",n/a,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:35:47,1642967009,5/25/2015 10:35:09,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],have been studied in,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:35:56,1642967106,5/25/2015 10:35:38,false,elite,1.0,29216552,USA,"","",172.164.31.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],have been studied in,N/A,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 10:39:07,1642970236,5/25/2015 10:38:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],"have been studied without significant clinical benefit,",n/a,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445979,5/25/2015 11:22:16,1642981286,5/25/2015 11:21:56,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","significant clinical benefit,",n,57,16,-1,70,35,TWrex-cause,800212-FS1,"Glucosamine and CHONDROITIN SULFATE have been studied in OSTEOARTHRITIS without significant clinical benefit, and few data support their use in RA.",OSTEOARTHRITIS,CHONDROITIN SULFATE
725445980,5/25/2015 09:39:26,1642952648,5/25/2015 09:39:14,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:02:59,1642956335,5/25/2015 10:02:31,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[MANIFESTATION] [ASSOCIATED_WITH] [PART_OF] [OTHER] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:04:54,1642956634,5/25/2015 10:03:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]",Hyperphosphatemia in Chronic Renal Failure (oral therapy) Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,n/a,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:05:24,1642956703,5/25/2015 10:04:38,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS] [OTHER],"[TREATS]
[OTHER]",are considered,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:07:41,1642957008,5/25/2015 10:07:15,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],are considered,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:35:06,1642966389,5/25/2015 10:34:32,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],considered the salts of choice,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:37:35,1642968732,5/25/2015 10:36:45,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],Chronic Renal Failure therapy) CALCIUM CARBONATE,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:40:28,1642971464,5/25/2015 10:40:06,false,elite,1.0,29216552,USA,"","",172.164.31.187,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",are considered the,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:40:57,1642971860,5/25/2015 10:39:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],(oral therapy),n/a,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:43:07,1642973514,5/25/2015 10:41:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],salts of choice for,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 10:44:53,1642974454,5/25/2015 10:44:07,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy),n/a,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 11:23:53,1642981635,5/25/2015 11:23:24,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],salts of choice for,n,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 11:38:39,1642984398,5/25/2015 11:38:16,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],(oral therapy) for,N/a,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 11:40:16,1642984689,5/25/2015 11:39:51,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],are the salts of choice for,N/A,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445980,5/25/2015 11:43:07,1642985351,5/25/2015 11:42:17,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[NONE],[NONE],n/a,I don't know,141,84,-1,161,101,TWrex-cause,800735-FS1,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and CALCIUM CARBONATE are considered the salts of choice for CHRONIC RENAL FAILURE,CHRONIC RENAL FAILURE,CALCIUM CARBONATE
725445981,5/25/2015 12:12:42,1642991325,5/25/2015 12:12:13,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[CAUSES],[CAUSES],PYKNODYSOSTOSIS: SHORT STATURE,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:14:04,1642991776,5/25/2015 12:13:38,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PYKNODYSOSTOSIS: autosomal recessive disorder, SHORT STATURE",NONE,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:18:03,1642992748,5/25/2015 12:17:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],becomes evident,n/a,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:44:31,1642998110,5/25/2015 12:44:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PYKNODYSOSTOSIS:,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:45:23,1642998220,5/25/2015 12:44:49,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A],[IS_A],is,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:53:19,1642999732,5/25/2015 12:52:44,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],becomes evident,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:54:05,1642999886,5/25/2015 12:53:03,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],becomes evident,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 12:54:49,1643000039,5/25/2015 12:54:10,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PYKNODYSOSTOSIS: In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",n/a,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:01:49,1643001264,5/25/2015 13:01:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PYKNODYSOSTOSIS: SHORT STATURE,na,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:06:23,1643002079,5/25/2015 13:06:00,false,neodev,1.0,31726043,GBR,"","",88.150.133.60,[CONTRAINDICATES],[CONTRAINDICATES],becomes,ggg,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:09:43,1643002586,5/25/2015 13:08:46,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"In autosomal recessive disorder, becomes evident in early childhood;",N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:10:03,1643002626,5/25/2015 13:09:10,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","In this autosomal recessive disorder, becomes evident in early childhood;",N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:10:53,1643002878,5/25/2015 13:10:42,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:12:28,1643003112,5/25/2015 13:10:45,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[MANIFESTATION],[MANIFESTATION],SHORT STATURE becomes evident,Says this becomes evident while having this disease,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445981,5/25/2015 13:12:38,1643003125,5/25/2015 13:12:24,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[IS_A],[IS_A],this,N/A,56,0,1,68,15,TWrex-cause,813251-FS1,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS
725445982,5/25/2015 08:10:40,1642937826,5/25/2015 08:10:20,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:22:18,1642940058,5/25/2015 08:22:04,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:25:28,1642940715,5/25/2015 08:25:11,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:34:36,1642942099,5/25/2015 08:34:19,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],treatment with for,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:40:15,1642943217,5/25/2015 08:39:59,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:41:34,1642943363,5/25/2015 08:41:10,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:43:17,1642943689,5/25/2015 08:42:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treatment with,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:44:50,1642943894,5/25/2015 08:44:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment with,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:53:31,1642945473,5/25/2015 08:53:14,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 08:55:54,1642945751,5/25/2015 08:55:04,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 09:00:35,1642946427,5/25/2015 09:00:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treatment with,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 09:04:13,1642946882,5/25/2015 09:03:59,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 09:13:21,1642948275,5/25/2015 09:12:59,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 09:15:49,1642948647,5/25/2015 09:15:07,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treatment with,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445982,5/25/2015 09:17:06,1642948888,5/25/2015 09:15:17,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,108,77,-1,125,95,TWrex-cause,803694-FS1,"Neely EK, Hintz RL, Parker B et al. Two year results of treatment with depot LEUPROLIDE ACETATE for central PRECOCIOUS PUBERTY",PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE
725445983,5/25/2015 09:18:02,1642949033,5/25/2015 09:17:27,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:26:30,1642950309,5/25/2015 09:26:17,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],for the treatment of,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:27:41,1642950582,5/25/2015 09:27:04,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF] [TREATS],"[TREATS]
[IS_A]
[PART_OF]",a treatment of a,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:31:46,1642951184,5/25/2015 09:31:29,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [NONE] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[OTHER]
[NONE]",N/A,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:34:33,1642951721,5/25/2015 09:34:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:35:18,1642951878,5/25/2015 09:34:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:48:18,1642953871,5/25/2015 09:47:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS:,n/a,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:56:13,1642955075,5/25/2015 09:56:01,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [CONTRAINDICATES] [OTHER] [NONE] [PART_OF],"[TREATS]
[CONTRAINDICATES]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 09:57:04,1642955243,5/25/2015 09:56:31,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],the treatment of,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:00:01,1642955868,5/25/2015 09:59:31,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:26:42,1642961474,5/25/2015 10:26:20,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:26:58,1642961547,5/25/2015 10:26:32,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ADAPALENE BENZOYL PEROXIDE treatment of ACNE VULGARIS:,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:31:48,1642964070,5/25/2015 10:31:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:32:01,1642964188,5/25/2015 10:31:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445983,5/25/2015 10:33:57,1642965468,5/25/2015 10:33:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the treatment of,n/a,104,12,-1,116,38,TWrex-cause,800461-FS1,"2009 11 01  ADAPALENE BENZOYL PEROXIDE a unique fixed dose combination topical gel for the treatment of ACNE VULGARIS: a transatlantic, randomized, double blind, controlled study in 1670 patients.",ACNE VULGARIS,ADAPALENE BENZOYL PEROXIDE
725445984,5/25/2015 09:18:49,1642949126,5/25/2015 09:18:35,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],information,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:27:33,1642950569,5/25/2015 09:27:15,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",control clinical trial of fluconazole vs.,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:30:13,1642950911,5/25/2015 09:29:20,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",A of a of of,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:32:37,1642951358,5/25/2015 09:32:26,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",N/A,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:35:36,1642951990,5/25/2015 09:35:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],suppression,n/a,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:52:07,1642954492,5/25/2015 09:50:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,n/a,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:58:32,1642955586,5/25/2015 09:57:57,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [CAUSES] [ASSOCIATED_WITH] [NONE],"[TREATS]
[CAUSES]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 09:59:33,1642955826,5/25/2015 09:59:01,false,elite,1.0,29216689,USA,"","",172.164.61.103,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",for suppression of,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:02:11,1642956191,5/25/2015 10:01:41,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],results of,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:28:24,1642962188,5/25/2015 10:27:56,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],suppression,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:29:16,1642962583,5/25/2015 10:28:40,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:34:01,1642965508,5/25/2015 10:33:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],for suppression,n/a,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:35:05,1642966378,5/25/2015 10:34:09,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],suppression of,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:35:37,1642966859,5/25/2015 10:35:18,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],for suppression of,N/A,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445984,5/25/2015 10:38:35,1642969754,5/25/2015 10:38:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for suppression of,n/a,136,102,-1,158,116,TWrex-cause,803456-FS1,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725445985,5/25/2015 09:29:27,1642950858,5/25/2015 09:29:16,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],may be treated with,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 09:37:15,1642952298,5/25/2015 09:37:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treated,n/a,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 09:38:05,1642952423,5/25/2015 09:37:52,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[SIDE_EFFECT] [NONE] [OTHER] [PART_OF],"[SIDE_EFFECT]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:00:02,1642955869,5/25/2015 09:59:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [TREATS],"[TREATS]
[SYMPTOM]",Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,n/a,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:00:58,1642955958,5/25/2015 10:00:45,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [ASSOCIATED_WITH] [OTHER] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:03:04,1642956344,5/25/2015 10:02:48,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],may be treated with,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:05:41,1642956748,5/25/2015 10:05:18,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],may be treated with,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:32:58,1642964810,5/25/2015 10:32:28,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treated,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:34:04,1642965551,5/25/2015 10:33:40,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:37:44,1642968872,5/25/2015 10:37:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated,n/a,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:38:31,1642969711,5/25/2015 10:38:15,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],may be treated with,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:39:27,1642970542,5/25/2015 10:39:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],may be treated with,N/A,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 10:42:47,1642973257,5/25/2015 10:42:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],may be treated with,n/a,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 11:21:31,1642981109,5/25/2015 11:21:18,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treated,n,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445985,5/25/2015 11:37:08,1642984208,5/25/2015 11:36:53,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],may be treated with,N/a,17,63,-1,41,71,TWrex-cause,803459-FS1,38   Jet lag and SHIFT WORK SLEEP DISORDER may be treated with ZOLPIDEM for insomnia symptoms.,SHIFT WORK SLEEP DISORDER,ZOLPIDEM
725445986,5/25/2015 10:46:51,1642974929,5/25/2015 10:46:28,false,elite,1.0,29216552,USA,"","",172.164.31.187,[CAUSES],[CAUSES],caused by,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 10:54:41,1642976084,5/25/2015 10:54:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 11:30:33,1642982877,5/25/2015 11:30:22,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 11:45:23,1642985781,5/25/2015 11:45:09,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],caused by,N/a,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 11:48:10,1642986299,5/25/2015 11:47:59,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:02:25,1642988994,5/25/2015 12:02:03,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[CAUSES],[CAUSES],PLAGUE PNEUMONIA DISEASE YERSINIA PESTIS,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:03:45,1642989261,5/25/2015 12:02:52,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],caused,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:06:45,1642989826,5/25/2015 12:06:25,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CAUSES],[CAUSES],PLAGUE PNEUMONIA DISEASE caused YERSINIA PESTIS,NONE,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:11:45,1642990971,5/25/2015 12:11:27,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:12:37,1642991291,5/25/2015 12:12:26,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:28:02,1642994751,5/25/2015 12:27:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],PLAGUE PNEUMONIA DISEASE caused by YERSINIA PESTIS,n/a,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:32:00,1642995598,5/25/2015 12:31:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],YERSINIA PESTIS,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:36:06,1642996573,5/25/2015 12:35:31,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],caused,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:36:27,1642996654,5/25/2015 12:36:13,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by,N/A,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445986,5/25/2015 12:46:57,1642998521,5/25/2015 12:46:45,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,43,79,1,66,94,TWrex-cause,810389-FS1,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS
725445987,5/25/2015 08:13:06,1642938247,5/25/2015 08:12:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[LOCATION],[LOCATION],on the,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:24:43,1642940619,5/25/2015 08:24:09,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],on,n/a,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:30:44,1642941376,5/25/2015 08:30:25,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:39:51,1642943151,5/25/2015 08:39:24,false,elite,1.0,29216801,USA,"","",172.162.14.122,[IS_A],[IS_A],is,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:42:44,1642943579,5/25/2015 08:42:27,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:46:11,1642944132,5/25/2015 08:45:19,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER] [MANIFESTATION],"[MANIFESTATION]
[OTHER]",growths,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:47:49,1642944334,5/25/2015 08:47:00,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is of of of with of,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:49:51,1642944806,5/25/2015 08:49:06,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],on LOWER SPINAL CORD,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:55:10,1642945690,5/25/2015 08:54:57,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],involvement,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 08:59:57,1642946325,5/25/2015 08:59:04,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[CAUSES] [LOCATION] [SYMPTOM],"[CAUSES]
[LOCATION]
[SYMPTOM]",causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 09:04:40,1642947006,5/25/2015 09:03:36,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [CAUSES] [PART_OF] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is of causing of of with of,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 09:06:14,1642947356,5/25/2015 09:05:47,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 09:15:09,1642948508,5/25/2015 09:14:55,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 09:20:49,1642949465,5/25/2015 09:19:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF] [CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is of causing of of with of,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445987,5/25/2015 09:23:20,1642949783,5/25/2015 09:22:17,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],causing,N/A,253,37,-1,278,56,TWrex-cause,802405-FS1,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY
725445988,5/25/2015 09:07:23,1642947533,5/25/2015 09:07:08,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],during,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:16:13,1642948745,5/25/2015 09:16:00,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],THERAPY,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:23:24,1642949796,5/25/2015 09:22:49,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS],[TREATS],THERAPY,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:24:55,1642949960,5/25/2015 09:24:37,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],THERAPY during,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:28:49,1642950762,5/25/2015 09:28:03,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",N/A,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:29:21,1642950848,5/25/2015 09:28:14,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[OTHER],[OTHER],during PREGNANCY,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:32:49,1642951413,5/25/2015 09:32:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[OTHER] [TREATS],"[TREATS]
[OTHER]",during,n/a,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:42:18,1642953041,5/25/2015 09:41:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],NICOTINE REPLACEMENT THERAPY during PREGNANCY,n/a,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:52:48,1642954576,5/25/2015 09:51:48,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[PREVENTS],[PREVENTS],during,no,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:54:16,1642954709,5/25/2015 09:54:01,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [SIDE_EFFECT] [OTHER] [NONE],"[CAUSES]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:54:29,1642954722,5/25/2015 09:54:01,false,elite,1.0,29216689,USA,"","",172.164.61.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:56:37,1642955174,5/25/2015 09:56:13,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],THERAPY,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 09:59:30,1642955797,5/25/2015 09:58:52,false,prodege,1.0,32672123,USA,CA,Irvine,192.171.229.225,[NONE],[NONE],N/A,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 10:22:16,1642959874,5/25/2015 10:21:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,it does not give any details at all,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445988,5/25/2015 10:24:14,1642960573,5/25/2015 10:23:43,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],REPLACEMENT during,N/A,36,0,1,44,28,TWrex-cause,811999-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
725445989,5/25/2015 09:30:32,1642950992,5/25/2015 09:29:42,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 09:37:39,1642952365,5/25/2015 09:37:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused,n/a,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 09:38:31,1642952490,5/25/2015 09:38:20,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[CAUSES] [SIDE_EFFECT] [MANIFESTATION] [LOCATION] [ASSOCIATED_WITH] [NONE],"[CAUSES]
[LOCATION]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:01:39,1642956151,5/25/2015 10:00:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Blastomycosis Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by BLASTOMYCES DERMATITIDIS,n/a,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:01:58,1642956178,5/25/2015 10:01:28,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [LOCATION] [NONE],"[TREATS]
[LOCATION]
[NONE]",N/A,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:03:53,1642956477,5/25/2015 10:03:32,false,elite,1.0,29216689,USA,"","",172.164.61.103,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:06:29,1642956878,5/25/2015 10:06:14,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:33:44,1642965303,5/25/2015 10:33:23,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],caused,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:35:47,1642966991,5/25/2015 10:35:23,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by BLASTOMYCES DERMATITIDIS,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:38:39,1642969811,5/25/2015 10:38:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",caused by,n/a,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:39:16,1642970397,5/25/2015 10:39:02,false,elite,1.0,29216552,USA,"","",172.164.31.187,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:40:46,1642971708,5/25/2015 10:39:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 10:43:32,1642973750,5/25/2015 10:43:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 11:22:49,1642981418,5/25/2015 11:22:16,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445989,5/25/2015 11:37:57,1642984336,5/25/2015 11:37:19,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811519-FS1,423  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725445990,5/25/2015 08:11:53,1642938092,5/25/2015 08:11:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:23:18,1642940325,5/25/2015 08:22:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:27:02,1642940936,5/25/2015 08:26:42,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:36:00,1642942448,5/25/2015 08:35:15,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],therapy for,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:41:24,1642943344,5/25/2015 08:41:04,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:43:43,1642943759,5/25/2015 08:42:55,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:45:24,1642944045,5/25/2015 08:44:52,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:48:01,1642944358,5/25/2015 08:46:32,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],thromboprophylaxis,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:54:25,1642945584,5/25/2015 08:54:12,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 08:58:04,1642946147,5/25/2015 08:57:13,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",VENOUS THROMBOEMBOLISM Low molecular weight HEPARIN,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 09:02:08,1642946696,5/25/2015 09:01:39,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],a,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 09:05:05,1642947104,5/25/2015 09:04:48,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 09:14:25,1642948450,5/25/2015 09:14:11,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],therapy,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 09:18:10,1642949044,5/25/2015 09:17:28,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],a,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445990,5/25/2015 09:18:37,1642949104,5/25/2015 09:17:08,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],weight HEPARIN versus compression stockings for thromboprophylaxis,N/A,102,147,-1,123,154,TWrex-cause,804670-FS1,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for VENOUS THROMBOEMBOLISM  Low molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,VENOUS THROMBOEMBOLISM,HEPARIN
725445991,5/25/2015 11:31:20,1642983010,5/25/2015 11:31:08,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Initiate therapy,n,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 11:46:41,1642986011,5/25/2015 11:46:26,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],therapy with,N/a,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 11:50:04,1642986733,5/25/2015 11:49:37,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],therapy with,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:04:30,1642989376,5/25/2015 12:03:48,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[PART_OF],[PART_OF],HYPERTENSION enalapril/HYDROCHLOROTHIAZIDE,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:06:42,1642989823,5/25/2015 12:05:31,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],Initiate therapy with,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:08:09,1642990140,5/25/2015 12:07:42,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],HYPERTENSION Therapy Initiate enalapril/HYDROCHLOROTHIAZIDE fixed lower end,NONE,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:12:58,1642991411,5/25/2015 12:12:38,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],Initiate therapy,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:13:32,1642991568,5/25/2015 12:13:16,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy,n/a,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:30:03,1642995178,5/25/2015 12:29:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,n/a,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:34:22,1642996232,5/25/2015 12:33:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTENSION,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:37:35,1642996947,5/25/2015 12:37:17,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:39:49,1642997329,5/25/2015 12:38:10,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SIDE_EFFECT],[SIDE_EFFECT],Initiate therapy at lower end of usual range.,N/A,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:47:39,1642998681,5/25/2015 12:47:29,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:48:08,1642998739,5/25/2015 12:47:50,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445991,5/25/2015 12:49:07,1642999005,5/25/2015 12:48:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],HYPERTENSION Therapy with enalapril/HYDROCHLOROTHIAZIDE,na,23,126,-1,34,145,TWrex-cause,804154-FS1,1  Geriatric Patients  HYPERTENSION  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,HYPERTENSION,HYDROCHLOROTHIAZIDE
725445992,5/25/2015 09:16:43,1642948817,5/25/2015 09:16:31,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],symptoms,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:25:36,1642950053,5/25/2015 09:24:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[OTHER] [SYMPTOM] [PART_OF] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]
[OTHER]",Other symptoms of or is with,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:25:44,1642950069,5/25/2015 09:25:22,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[SYMPTOM],[SYMPTOM],symptoms,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:30:45,1642951030,5/25/2015 09:30:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],Other symptoms,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:30:55,1642951049,5/25/2015 09:30:38,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[CAUSES] [OTHER] [NONE],"[CAUSES]
[OTHER]
[NONE]",N/A,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:33:39,1642951598,5/25/2015 09:33:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],symptoms,n/a,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:44:42,1642953369,5/25/2015 09:43:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",n/a,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:53:32,1642954636,5/25/2015 09:53:17,false,prodege,1.0,2044524,GBR,Z7,Macclesfield,213.104.15.106,[CAUSES],[CAUSES],diagnosis,n/a,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:55:14,1642954893,5/25/2015 09:54:52,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [CONTRAINDICATES] [SYMPTOM] [LOCATION] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:55:27,1642954963,5/25/2015 09:55:03,false,elite,1.0,29216689,USA,"","",172.164.61.103,[SYMPTOM],[SYMPTOM],including,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 09:58:09,1642955484,5/25/2015 09:57:31,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],"may be present,",N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 10:24:59,1642960877,5/25/2015 10:23:40,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,both of them are just symptoms of another problem,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 10:25:12,1642960963,5/25/2015 10:24:40,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],significant secondary diagnosis,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 10:27:37,1642961836,5/25/2015 10:25:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],Other symptoms,N/A,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445992,5/25/2015 10:30:20,1642963140,5/25/2015 10:29:33,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],"symptoms present,",n/a,52,90,1,59,110,TWrex-cause,813142-FS1,"Other symptoms of colitis may be present, including DIARRHEA and bleeding or weight loss  ANAL CROHN'S DISEASE is the most significant secondary diagnosis to consider in patients with atypical fissures.",DIARRHEA,ANAL CROHN'S DISEASE
725445993,5/25/2015 09:18:33,1642949101,5/25/2015 09:18:19,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],"suppression,",N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:27:14,1642950488,5/25/2015 09:27:02,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[IS_A],[IS_A],(principally,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:29:16,1642950836,5/25/2015 09:28:37,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]
[PART_OF]",Effects of of drug of,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:32:24,1642951308,5/25/2015 09:31:59,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[CAUSES] [ASSOCIATED_WITH] [NONE],"[CAUSES]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:35:23,1642951912,5/25/2015 09:35:03,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(principally,n/a,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:50:57,1642954282,5/25/2015 09:49:36,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]","Hematologic Effects High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",n/a,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:57:53,1642955449,5/25/2015 09:57:21,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [NONE] [PREVENTS] [TREATS],"[TREATS]
[PREVENTS]
[LOCATION]
[NONE]",N/A,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 09:58:59,1642955669,5/25/2015 09:58:24,false,elite,1.0,29216689,USA,"","",172.164.61.103,[IS_A],[IS_A],(principally,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:01:40,1642956150,5/25/2015 10:00:57,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],manifested as,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:27:56,1642961946,5/25/2015 10:27:36,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PART_OF],[PART_OF],(principally,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:28:39,1642962271,5/25/2015 10:27:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],LEUKOPENIA (principally GRANULOCYTOPENIA;,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:33:42,1642965286,5/25/2015 10:33:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(principally,n/a,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:34:05,1642965589,5/25/2015 10:33:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],(principally,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:35:17,1642966599,5/25/2015 10:34:09,false,elite,1.0,29216552,USA,"","",172.164.31.187,[IS_A],[IS_A],(principally,N/A,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445993,5/25/2015 10:38:03,1642969182,5/25/2015 10:36:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],(principally,n/a,95,119,1,104,135,TWrex-cause,812572-FS1,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as LEUKOPENIA (principally GRANULOCYTOPENIA; severity depends on dose of drug and on regenerative capacity of bone marrow.",LEUKOPENIA,GRANULOCYTOPENIA
725445994,5/25/2015 08:09:43,1642937662,5/25/2015 08:09:19,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],drug therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:21:22,1642939862,5/25/2015 08:20:33,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:24:38,1642940610,5/25/2015 08:24:25,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:33:22,1642941838,5/25/2015 08:32:43,false,elite,1.0,29216801,USA,"","",172.162.14.122,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:39:16,1642943015,5/25/2015 08:38:58,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:39:25,1642943078,5/25/2015 08:38:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",may be preferred,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:40:56,1642943312,5/25/2015 08:40:03,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",drug or is or,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:43:11,1642943641,5/25/2015 08:42:35,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],preferred therapy during PREGNANCY,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:52:40,1642945329,5/25/2015 08:52:18,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:53:44,1642945486,5/25/2015 08:53:07,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],may be preferred therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 08:59:21,1642946262,5/25/2015 08:58:54,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",drug or is or,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 09:03:13,1642946804,5/25/2015 09:02:59,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 09:12:18,1642948219,5/25/2015 09:12:06,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],drug therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 09:13:16,1642948260,5/25/2015 09:11:44,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],antithyroid drug therapy,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445994,5/25/2015 09:15:03,1642948503,5/25/2015 09:14:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug or or,N/A,82,0,-1,90,16,TWrex-cause,803224-FS1,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL
725445995,5/25/2015 11:48:00,1642986255,5/25/2015 11:47:27,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Individuals who do not have BWS can also have HEMIHYPERTROPHY,N/a,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 11:51:37,1642987019,5/25/2015 11:50:52,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Related but not by above relations.,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:06:26,1642989800,5/25/2015 12:05:55,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[SIDE_EFFECT],[SIDE_EFFECT],BWS HEMIHYPERTROPHY,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:09:21,1642990381,5/25/2015 12:08:54,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[OTHER],[OTHER],do not have BWS can have HEMIHYPERTROPHY,NONE,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:09:52,1642990472,5/25/2015 12:08:42,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[CAUSES],[CAUSES],have,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:14:23,1642991838,5/25/2015 12:14:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also,n/a,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:31:12,1642995442,5/25/2015 12:30:50,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Individuals who do not have BWS can also have HEMIHYPERTROPHY,n/a,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:33:55,1642996109,5/25/2015 12:33:25,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[NONE],[NONE],N/A,STATEMENT OF FACT,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:36:57,1642996763,5/25/2015 12:36:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HEMIHYPERTROPHY,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:39:18,1642997166,5/25/2015 12:38:42,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES],[CAUSES],can,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:43:03,1642997963,5/25/2015 12:42:03,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[MANIFESTATION],[MANIFESTATION],can also have,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:48:26,1642998849,5/25/2015 12:48:16,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:51:03,1642999319,5/25/2015 12:50:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Individuals who do not have BWS can have HEMIHYPERTROPHY,na,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:52:48,1642999657,5/25/2015 12:52:25,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[OTHER],[OTHER],also have,n/a,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445995,5/25/2015 12:59:39,1643000898,5/25/2015 12:58:09,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",who do not have can also have,N/A,46,28,1,60,31,TWrex-cause,813300-FS1,Individuals who do not have BWS can also have HEMIHYPERTROPHY,HEMIHYPERTROPHY,BWS
725445996,5/25/2015 10:40:44,1642971685,5/25/2015 10:40:23,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[MANIFESTATION],[MANIFESTATION],diagnosis difficult to isolate,N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 10:44:42,1642974323,5/25/2015 10:44:07,false,elite,1.0,29216552,USA,"","",172.164.31.187,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]",confirmed by,N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 10:46:26,1642974829,5/25/2015 10:45:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis is difficult,n/a,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 10:50:09,1642975446,5/25/2015 10:49:38,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],difficult to isolate,n/a,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 10:51:49,1642975703,5/25/2015 10:51:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],The diagnosis of,N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 11:27:58,1642982427,5/25/2015 11:27:41,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],confirmed by,n,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 11:43:12,1642985379,5/25/2015 11:42:17,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],diagnosis of,N/a,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 11:45:54,1642985842,5/25/2015 11:45:14,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,"Related, but not expressed by terms above.",17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 11:55:59,1642987824,5/25/2015 11:55:27,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PSITTACOSIS C PSITTACI,N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 11:56:41,1642987900,5/25/2015 11:53:49,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],"confirmed serologic studies, because",N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 12:04:28,1642989375,5/25/2015 12:04:01,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis of PSITTACOSIS C PSITTACI is difficult to isolate,NONE,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 12:09:40,1642990420,5/25/2015 12:09:19,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],"confirmed by serologic studies,",N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 12:11:07,1642990711,5/25/2015 12:10:51,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],diagnosis,n/a,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 12:24:42,1642994093,5/25/2015 12:24:21,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"diagnosis of PSITTACOSIS is best confirmed by serologic studies,",n/a,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445996,5/25/2015 12:27:38,1642994634,5/25/2015 12:26:33,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PSITTACOSIS,N/A,17,78,1,27,88,TWrex-cause,811122-FS1,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because  C PSITTACI  is difficult to isolate from blood or infected secretions.",PSITTACOSIS,C PSITTACI
725445997,5/25/2015 10:12:06,1642957682,5/25/2015 10:11:25,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],did not reduce,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:39:38,1642970734,5/25/2015 10:38:50,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PREVENTS],[PREVENTS],did not reduce but incidence,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:43:07,1642973518,5/25/2015 10:41:55,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ASPIRIN reduce INFARCTION,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:43:33,1642973753,5/25/2015 10:42:55,false,elite,1.0,29216552,USA,"","",172.164.31.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"trials, did not reduce",N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:44:36,1642974294,5/25/2015 10:44:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],did not reduce,n/a,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:49:11,1642975314,5/25/2015 10:48:09,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],"trials, did not reduce",n/a,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 10:50:39,1642975527,5/25/2015 10:50:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],did not reduce,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 11:27:16,1642982332,5/25/2015 11:27:02,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],reduce,n,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 11:41:50,1642984981,5/25/2015 11:41:27,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CONTRAINDICATES],[CONTRAINDICATES],did not reduce myocardial,N/a,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 11:44:18,1642985547,5/25/2015 11:43:47,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS] [OTHER],"[PREVENTS]
[OTHER]",did not reduce,Inversely related.,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 11:51:49,1642987058,5/25/2015 11:48:57,false,clixsense,1.0,31345986,GBR,"","",86.165.143.234,[NONE],[NONE],N/A,The use of aspirin did not reduce the incidence of infarction therefore there is no relationship,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 11:54:51,1642987593,5/25/2015 11:53:52,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[TREATS],[TREATS],ASPIRIN INFARCTION,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 12:03:26,1642989203,5/25/2015 12:02:44,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[MANIFESTATION],[MANIFESTATION],ASPIRIN not reduce myocardial INFARCTION death lowered incidence ischemic stroke,NONE,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 12:08:23,1642990202,5/25/2015 12:08:04,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[PREVENTS],[PREVENTS],lowered the incidence,N/A,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445997,5/25/2015 12:10:31,1642990586,5/25/2015 12:10:02,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],reduce,n/a,66,32,-1,75,39,TWrex-cause,800872-FS1,"In contrast to previous trials, ASPIRIN did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",INFARCTION,ASPIRIN
725445998,5/25/2015 10:46:03,1642974761,5/25/2015 10:45:38,false,elite,1.0,29216552,USA,"","",172.164.31.187,[SYMPTOM],[SYMPTOM],Stinging,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 10:53:47,1642975947,5/25/2015 10:50:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],Stinging PAIN in the anterolateral thigh.,n/a,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 11:30:06,1642982775,5/25/2015 11:29:40,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Occasionally followed by,n,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 11:44:27,1642985623,5/25/2015 11:44:02,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/a,Unrelated terms.,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 11:47:28,1642986136,5/25/2015 11:46:56,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation.,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:00:10,1642988469,5/25/2015 11:59:32,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[SYMPTOM],[SYMPTOM],MERALGIA PARESTHETICA PAIN,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:01:44,1642988799,5/25/2015 11:59:20,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],PAIN,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:05:49,1642989718,5/25/2015 12:05:26,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[SYMPTOM],[SYMPTOM],MERALGIA PARESTHETICA Stinging PAIN,NONE,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:11:05,1642990699,5/25/2015 12:10:27,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER] [CAUSES],"[CAUSES]
[OTHER]",Stinging,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:11:58,1642991026,5/25/2015 12:11:37,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],followed by,n/a,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:27:09,1642994559,5/25/2015 12:26:39,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Occasionally followed by shoulder girdle muscle atrophy Entrapment MERALGIA PARESTHETICA Lateral femoral cutaneous,n/a,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:30:52,1642995343,5/25/2015 12:30:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],Stinging PAIN,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:34:19,1642996230,5/25/2015 12:33:09,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],No,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:35:44,1642996489,5/25/2015 12:35:27,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],by,N/A,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445998,5/25/2015 12:46:20,1642998415,5/25/2015 12:46:05,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,143,68,1,146,89,TWrex-cause,814634-FS1,Occasionally followed by shoulder girdle muscle atrophy  Entrapment MERALGIA PARESTHETICA  Lateral femoral cutaneous  Thigh  Yes  No  Stinging PAIN in the anterolateral thigh.,PAIN,MERALGIA PARESTHETICA
725445999,5/25/2015 09:28:07,1642950649,5/25/2015 09:27:53,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",manifestations of,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 09:33:06,1642951502,5/25/2015 09:32:53,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [SIDE_EFFECT] [ASSOCIATED_WITH] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 09:36:05,1642952059,5/25/2015 09:35:50,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(i.e.,",n/a,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 09:54:46,1642954774,5/25/2015 09:53:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]","PATHOGENESIS The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",n/a,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 09:59:16,1642955746,5/25/2015 09:59:04,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[NONE]",N/A,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:00:34,1642955910,5/25/2015 09:59:56,false,elite,1.0,29216689,USA,"","",172.164.61.103,[IS_A],[IS_A],"(i.e.,",N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:03:20,1642956364,5/25/2015 10:02:44,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],cause of results in,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:29:53,1642962847,5/25/2015 10:29:06,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[MANIFESTATION],[MANIFESTATION],manifestations,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:30:36,1642963264,5/25/2015 10:29:53,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"manifestations of PCD (i.e., DEXTROCARDIA",N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:35:19,1642966626,5/25/2015 10:34:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],manifestations of,n/a,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:36:24,1642967562,5/25/2015 10:35:57,false,elite,1.0,29216552,USA,"","",172.164.31.187,[IS_A] [OTHER],"[IS_A]
[OTHER]","(i.e.,",N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:36:29,1642967680,5/25/2015 10:35:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],manifestations of,N/A,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 10:39:30,1642970609,5/25/2015 10:39:08,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],manifestations,n/a,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 11:19:55,1642980811,5/25/2015 11:19:33,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],manifestations,n,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725445999,5/25/2015 11:35:27,1642983867,5/25/2015 11:34:57,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[MANIFESTATION],[MANIFESTATION],manifestations of,N/a,93,66,1,104,69,TWrex-cause,812974-FS1,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, DEXTROCARDIA and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left right symmetry in the embryo; and (3) to propel spermatzoa forward.",DEXTROCARDIA,PCD
725446000,5/25/2015 09:30:46,1642951026,5/25/2015 09:30:33,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 09:38:47,1642952541,5/25/2015 09:38:33,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[NONE] [SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]
[NONE]",N/A,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:02:13,1642956198,5/25/2015 10:02:00,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [MANIFESTATION] [SIDE_EFFECT] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:02:30,1642956245,5/25/2015 10:01:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",DRUG THERAPY Introduction Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,n/a,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:04:13,1642956532,5/25/2015 10:03:55,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:06:57,1642956916,5/25/2015 10:06:30,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Use to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:34:06,1642965559,5/25/2015 10:33:45,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PREVENTS],[PREVENTS],DRUG THERAPY,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:36:12,1642967392,5/25/2015 10:35:48,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],WARFARIN to treat ACUTE PROXIMAL DVT,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:38:58,1642970080,5/25/2015 10:38:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],to treat,n/a,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:39:33,1642970669,5/25/2015 10:39:18,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:41:05,1642971961,5/25/2015 10:40:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 10:43:51,1642973901,5/25/2015 10:43:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Use to treat,n/a,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 11:23:08,1642981507,5/25/2015 11:22:50,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",to treat,n,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 11:37:56,1642984327,5/25/2015 11:37:39,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],to treat,N/a,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446000,5/25/2015 11:38:11,1642984368,5/25/2015 11:37:58,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],to treat,N/A,62,44,-1,79,52,TWrex-cause,803504-FS1,DRUG THERAPY  Introduction  Use heparin and WARFARIN to treat ACUTE PROXIMAL DVT and consider thrombolysis for patients with iliofemoral DVT.,ACUTE PROXIMAL DVT,WARFARIN
725446001,5/25/2015 08:02:21,1642936278,5/25/2015 08:01:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],should be evaluated,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:14:26,1642938491,5/25/2015 08:13:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],evaluated for,n/a,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:17:21,1642938993,5/25/2015 08:17:09,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],with,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:17:58,1642939125,5/25/2015 08:17:25,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],with,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:18:33,1642939261,5/25/2015 08:17:52,false,elite,1.0,29216801,USA,"","",172.162.14.122,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],should be evaluated for,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:19:45,1642939513,5/25/2015 08:19:32,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],systemic,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:21:33,1642939904,5/25/2015 08:19:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],should be evaluated,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:22:24,1642940079,5/25/2015 08:21:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],should be evaluated for,n/a,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:22:46,1642940195,5/25/2015 08:22:02,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",cause is with or of,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:26:19,1642940852,5/25/2015 08:25:47,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.116.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PHOTOSENSITIVITY evaluated for systemic or cutaneous lupus erythematosus,NONE,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:26:45,1642940913,5/25/2015 08:25:38,false,prodege,1.0,23930372,GBR,E2,Hastings,2.103.22.113,[ASSOCIATED_WITH],[ASSOCIATED_WITH],should be evaluated for,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:32:52,1642941729,5/25/2015 08:32:38,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],porphyria,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:33:00,1642941757,5/25/2015 08:32:15,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],patients should be evaluated for,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:36:12,1642942462,5/25/2015 08:34:26,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluated,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446001,5/25/2015 08:45:05,1642944014,5/25/2015 08:44:53,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],porphyria,N/A,54,158,1,69,176,TWrex-cause,813307-FS1,"Unless the cause is obvious, patients with pronounced PHOTOSENSITIVITY should be evaluated for systemic or cutaneous lupus erythematosus (see  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",PHOTOSENSITIVITY,SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
725446002,5/25/2015 11:31:46,1642983150,5/25/2015 11:31:21,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 11:47:08,1642986115,5/25/2015 11:46:46,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],caused by reactivation of,N/a,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 11:50:37,1642986826,5/25/2015 11:50:10,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],are caused by,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:05:09,1642989539,5/25/2015 12:04:33,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[CAUSES],[CAUSES],SHINGLES VARICELLA ZOSTER VIRUS,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:07:47,1642990065,5/25/2015 12:06:48,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],caused by,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:08:31,1642990236,5/25/2015 12:08:10,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CAUSES],[CAUSES],SHINGLES caused by reactivation of VARICELLA ZOSTER VIRUS,NONE,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:13:13,1642991454,5/25/2015 12:12:59,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by reactivation,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:13:46,1642991664,5/25/2015 12:13:33,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:30:31,1642995304,5/25/2015 12:30:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,n/a,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:35:04,1642996355,5/25/2015 12:34:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],VARICELLA ZOSTER VIRUS,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:38:03,1642996993,5/25/2015 12:37:38,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",caused by of a,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:40:50,1642997442,5/25/2015 12:39:51,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],are caused by reactivation,N/A,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:47:55,1642998709,5/25/2015 12:47:41,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:48:24,1642998841,5/25/2015 12:48:09,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446002,5/25/2015 12:49:43,1642999070,5/25/2015 12:49:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],SHINGLES caused by VARICELLA ZOSTER VIRUS (VZV),na,51,125,1,58,147,TWrex-cause,811528-FS1,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS
725446003,5/25/2015 09:29:15,1642950841,5/25/2015 09:29:00,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 09:37:03,1642952225,5/25/2015 09:36:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 09:37:51,1642952385,5/25/2015 09:37:40,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[NONE]",N/A,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 09:59:13,1642955734,5/25/2015 09:58:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Diagnosis Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",n/a,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:00:44,1642955919,5/25/2015 09:59:59,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE] [OTHER],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[OTHER]
[NONE]",N/A,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:02:46,1642956281,5/25/2015 10:02:08,false,elite,1.0,29216689,USA,"","",172.164.61.103,[IS_A] [OTHER],"[IS_A]
[OTHER]",is and,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:05:17,1642956701,5/25/2015 10:04:47,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],is defined by,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:32:27,1642964473,5/25/2015 10:31:54,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],defined,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:33:38,1642965261,5/25/2015 10:32:27,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],clinical findings: ANEMIA RENAL DYSFUNCTION,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:37:24,1642968550,5/25/2015 10:36:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],defined by clinical findings:,n/a,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:38:14,1642969361,5/25/2015 10:37:53,false,elite,1.0,29216552,USA,"","",172.164.31.187,[OTHER],[OTHER],and,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:39:08,1642970261,5/25/2015 10:38:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],TTP is defined by a pentad of clinical findings:,N/A,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 10:42:19,1642972881,5/25/2015 10:41:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,numerous findings,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 11:21:16,1642981047,5/25/2015 11:20:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],defined by,n,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446003,5/25/2015 11:36:52,1642984188,5/25/2015 11:36:23,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/a,Terms are unrelated,163,126,1,179,132,TWrex-cause,812859-FS1,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA neurologic abnormalities, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,ANEMIA
725446004,5/25/2015 12:11:00,1642990694,5/25/2015 12:10:13,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[CAUSES],[CAUSES],FMS PAIN,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:12:27,1642991235,5/25/2015 12:12:09,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[SYMPTOM],[SYMPTOM],FMS PAIN is real,NONE,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:16:55,1642992431,5/25/2015 12:16:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],real,n/a,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:42:53,1642997956,5/25/2015 12:42:25,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PAIN,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:43:26,1642998013,5/25/2015 12:43:10,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:49:11,1642999006,5/25/2015 12:48:10,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],is real,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:50:02,1642999151,5/25/2015 12:48:51,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],is real,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:52:31,1642999609,5/25/2015 12:52:07,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,n/a,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 12:59:34,1643000882,5/25/2015 12:59:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FMS PAIN,na,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:04:38,1643001724,5/25/2015 13:04:28,false,neodev,1.0,31726043,GBR,H9,London,37.157.247.44,[MANIFESTATION],[MANIFESTATION],not,hghhh,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:05:51,1643001895,5/25/2015 13:05:06,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],the PAIN is real,It indicates it is a part of the disease,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:06:05,1643001947,5/25/2015 13:05:10,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",does not 'kill but is real,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:06:33,1643002115,5/25/2015 13:05:42,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",does not 'kill is not imaginary,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:09:46,1643002587,5/25/2015 13:09:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446004,5/25/2015 13:11:30,1643002985,5/25/2015 13:11:15,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[CAUSES],[CAUSES],PAIN,N/A,56,17,1,59,20,TWrex-cause,813391-FS1,• Emphasize that FMS does not 'kill or cripple' but the PAIN is real and not imaginary,PAIN,FMS
725446005,5/25/2015 12:12:07,1642991072,5/25/2015 12:11:45,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[TREATS],[TREATS],TIMOLOL GLAUCOMA,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:13:36,1642991618,5/25/2015 12:13:14,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],Combined TIMOLOL epinephrine therapy open angle GLAUCOMA,NONE,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:17:46,1642992708,5/25/2015 12:17:33,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy,n/a,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:44:13,1642998075,5/25/2015 12:43:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],GLAUCOMA,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:44:46,1642998133,5/25/2015 12:44:17,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS],[TREATS],therapy,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:52:43,1642999640,5/25/2015 12:51:27,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[OTHER],[OTHER],therapy for,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:53:02,1642999691,5/25/2015 12:52:15,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],therapy,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 12:54:09,1642999906,5/25/2015 12:53:45,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA,n/a,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:01:17,1643001159,5/25/2015 13:00:52,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],TIMOLOL therapy for open angle GLAUCOMA,na,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:05:56,1643001924,5/25/2015 13:05:39,false,neodev,1.0,31726043,GBR,"","",88.150.175.253,[MANIFESTATION],[MANIFESTATION],epinephrine,jhjhj,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:08:42,1643002439,5/25/2015 13:07:49,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[TREATS] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]",epinephrine therapy for,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:09:05,1643002498,5/25/2015 13:08:15,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],epinephrine therapy for,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:10:41,1643002858,5/25/2015 13:10:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:10:44,1643002872,5/25/2015 13:09:43,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],therapy for,Says it's a therapy for the disease,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446005,5/25/2015 13:12:23,1643003111,5/25/2015 13:11:59,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[TREATS],[TREATS],therapy,N/A,95,48,-1,102,55,TWrex-cause,804284-FS1,"Knupp JA, Shields MB, Mandel AI et al. Combined TIMOLOL and epinephrine therapy for open angle GLAUCOMA",GLAUCOMA,TIMOLOL
725446006,5/25/2015 09:28:58,1642950802,5/25/2015 09:28:37,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],treatment course,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 09:36:47,1642952200,5/25/2015 09:36:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 09:37:38,1642952364,5/25/2015 09:37:28,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[SIDE_EFFECT] [NONE] [OTHER] [PART_OF] [IS_A],"[SIDE_EFFECT]
[IS_A]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 09:58:11,1642955502,5/25/2015 09:57:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS,n/a,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 09:59:58,1642955861,5/25/2015 09:59:46,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]
[NONE]",N/A,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:02:06,1642956186,5/25/2015 10:01:36,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",of,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:04:46,1642956625,5/25/2015 10:04:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment with,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:31:53,1642964109,5/25/2015 10:31:27,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:32:27,1642964451,5/25/2015 10:31:54,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],treatment with ALENDRONATE of postmenopausal OSTEOPOROSIS,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:36:35,1642967786,5/25/2015 10:36:14,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment course,n/a,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:37:52,1642969036,5/25/2015 10:37:23,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],treatment of,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:38:17,1642969418,5/25/2015 10:37:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment course with,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 10:41:45,1642972499,5/25/2015 10:41:26,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment course,n/a,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 11:20:51,1642980976,5/25/2015 11:20:34,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment course,n,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446006,5/25/2015 11:37:17,1642984262,5/25/2015 11:36:02,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],treatment with,N/A,119,89,-1,130,100,TWrex-cause,803474-FS1,"Rossini M, Gatti D, Zamberlan N et al. Long term effects of a treatment course with oral ALENDRONATE of postmenopausal OSTEOPOROSIS",OSTEOPOROSIS,ALENDRONATE
725446007,5/25/2015 08:04:03,1642936620,5/25/2015 08:03:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],clinical trial.,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:15:58,1642938760,5/25/2015 08:15:33,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],in,n/a,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:18:16,1642939200,5/25/2015 08:18:07,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],Procaccianti,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:20:08,1642939643,5/25/2015 08:19:31,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],trial.,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:20:41,1642939755,5/25/2015 08:20:28,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],blind,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:20:57,1642939810,5/25/2015 08:20:31,false,elite,1.0,29216801,USA,"","",172.162.14.122,[OTHER],[OTHER],in,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:24:29,1642940585,5/25/2015 08:23:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],trial.,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:24:36,1642940603,5/25/2015 08:24:07,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],double blind controlled clinical trial.,n/a,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:24:41,1642940615,5/25/2015 08:24:19,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],"A, a",N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:33:49,1642941930,5/25/2015 08:33:37,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],blind,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:35:15,1642942291,5/25/2015 08:34:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],trial.,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:39:06,1642942978,5/25/2015 08:38:09,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[SYMPTOM],[SYMPTOM],in,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:48:22,1642944468,5/25/2015 08:47:20,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],clinical,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:52:36,1642945320,5/25/2015 08:52:16,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],"A, a",N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446007,5/25/2015 08:58:36,1642946211,5/25/2015 08:57:05,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CONTRAINDICATES],[CONTRAINDICATES],controlled,N/A,80,65,-1,95,76,TWrex-cause,803353-FS1,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and PROPRANOLOL in ESSENTIAL TREMOR: a double blind controlled clinical trial.",ESSENTIAL TREMOR,PROPRANOLOL
725446008,5/25/2015 09:30:56,1642951057,5/25/2015 09:30:47,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 09:39:13,1642952614,5/25/2015 09:38:48,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:02:30,1642956243,5/25/2015 10:02:17,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [SYMPTOM] [CAUSES] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:03:31,1642956425,5/25/2015 10:02:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE,n/a,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:04:37,1642956604,5/25/2015 10:04:16,false,elite,1.0,29216689,USA,"","",172.164.61.103,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:07:15,1642956955,5/25/2015 10:06:59,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:34:31,1642965941,5/25/2015 10:34:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:36:42,1642967841,5/25/2015 10:36:13,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],CBACTERIAL VAGINOSIS: treatment ORAL METRONIDAZOLE,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:39:23,1642970513,5/25/2015 10:38:59,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment with,n/a,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:40:04,1642971074,5/25/2015 10:39:35,false,elite,1.0,29216552,USA,"","",172.164.31.187,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:41:33,1642972335,5/25/2015 10:41:09,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 10:44:06,1642974011,5/25/2015 10:43:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment,n/a,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 11:23:23,1642981559,5/25/2015 11:23:10,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment with,n,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 11:38:15,1642984375,5/25/2015 11:37:57,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],treatment with,N/a,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446008,5/25/2015 11:39:50,1642984580,5/25/2015 11:38:13,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],treatment with,N/A,33,94,-1,51,112,TWrex-cause,803751-FS1,"Schmitt C, Sobel JD, Meriwether CBACTERIAL VAGINOSIS: treatment with clindamycin cream versus ORAL METRONIDAZOLE",BACTERIAL VAGINOSIS,ORAL METRONIDAZOLE
725446009,5/25/2015 11:52:58,1642987390,5/25/2015 11:52:19,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",develops in patients with,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:07:22,1642989977,5/25/2015 12:06:57,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MACROGLOBULINEMIA MONOCLONAL GAMMOPATHY,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:10:08,1642990522,5/25/2015 12:09:46,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CAUSES],[CAUSES],MACROGLOBULINEMIA develops in 12% patients MONOCLONAL GAMMOPATHY,NONE,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:11:50,1642990994,5/25/2015 12:11:01,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],develops,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:14:59,1642991969,5/25/2015 12:14:44,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],develops,n/a,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:35:07,1642996379,5/25/2015 12:34:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],develops in about 12%,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:39:15,1642997159,5/25/2015 12:37:20,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MONOCLONAL GAMMOPATHY,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:39:21,1642997180,5/25/2015 12:39:01,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[MANIFESTATION],[MANIFESTATION],MACROGLOBULINEMIA develops about 12% of patients MONOCLONAL GAMMOPATHY,n/a,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:40:23,1642997371,5/25/2015 12:39:53,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:44:58,1642998148,5/25/2015 12:43:41,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],develops,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:48:50,1642998932,5/25/2015 12:48:40,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:53:33,1642999748,5/25/2015 12:53:12,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[ASSOCIATED_WITH],[ASSOCIATED_WITH],develops,n/a,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 12:56:19,1643000357,5/25/2015 12:55:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[MANIFESTATION],[MANIFESTATION],MACROGLOBULINEMIA develops in patients with MONOCLONAL GAMMOPATHY,na,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 13:01:18,1643001161,5/25/2015 13:00:10,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",develops in,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446009,5/25/2015 13:01:35,1643001232,5/25/2015 13:01:00,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[MANIFESTATION] [PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",develops in about 12%,N/A,57,0,1,77,17,TWrex-cause,814523-FS1,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA
725446010,5/25/2015 11:48:41,1642986444,5/25/2015 11:48:01,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PART_OF],[PART_OF],coexistent,N/a,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 11:52:18,1642987238,5/25/2015 11:51:45,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",patients may have coexistent,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:06:51,1642989831,5/25/2015 12:06:29,false,neodev,1.0,32438173,USA,VA,Manassas,207.244.77.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PRIMARY HEADACHE TENSION TYPE HEADACHE,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:09:44,1642990425,5/25/2015 12:09:23,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PRIMARY HEADACHE may have TENSION TYPE HEADACHE,NONE,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:10:59,1642990693,5/25/2015 12:09:54,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have coexistent,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:14:42,1642991907,5/25/2015 12:14:24,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:34:42,1642996302,5/25/2015 12:33:56,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[IS_A],[IS_A],coexistent,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:37:18,1642996886,5/25/2015 12:36:59,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PRIMARY HEADACHE,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:38:59,1642997130,5/25/2015 12:38:19,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],significant number of patients with PRIMARY HEADACHE may have coexistent migraine TENSION TYPE HEADACHE,n/a,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:39:47,1642997319,5/25/2015 12:39:22,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",A of with,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:43:40,1642998033,5/25/2015 12:43:04,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have coexistent,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:48:37,1642998895,5/25/2015 12:48:27,false,neodev,1.0,31789301,USA,NY,New York,192.241.140.200,[NONE],[NONE],no,no,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:51:43,1642999524,5/25/2015 12:51:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],patients with PRIMARY HEADACHE may have TENSION TYPE HEADACHE,na,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 12:53:10,1642999706,5/25/2015 12:52:49,false,gifthunterclub,1.0,31241093,GBR,C2,Brighouse,94.10.218.157,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may have,n/a,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446010,5/25/2015 13:00:52,1643001132,5/25/2015 12:59:42,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],may have,N/A,50,100,1,65,121,TWrex-cause,814009-FS1,Comments: • A significant number of patients with PRIMARY HEADACHE may have coexistent migraine and TENSION TYPE HEADACHE,PRIMARY HEADACHE,TENSION TYPE HEADACHE
725446011,5/25/2015 08:08:26,1642937340,5/25/2015 08:08:11,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatments for,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:19:32,1642939470,5/25/2015 08:19:17,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatments,n/a,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:23:20,1642940332,5/25/2015 08:23:07,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CONTRAINDICATES],[CONTRAINDICATES],uncomplicated,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:26:57,1642940932,5/25/2015 08:26:15,false,elite,1.0,29216801,USA,"","",172.162.14.122,[TREATS],[TREATS],treatments for,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:35:29,1642942364,5/25/2015 08:34:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatments for,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:36:38,1642942486,5/25/2015 08:36:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:37:34,1642942729,5/25/2015 08:36:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [TREATS],"[TREATS]
[IS_A]
[PART_OF]",A of treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:40:48,1642943291,5/25/2015 08:40:28,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:51:00,1642945011,5/25/2015 08:49:42,false,pocketmoneygpt,1.0,21432964,GBR,K5,Poole,109.155.122.13,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:51:17,1642945037,5/25/2015 08:51:03,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 08:57:33,1642946031,5/25/2015 08:57:03,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[PART_OF]",efficacy of,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 09:01:30,1642946604,5/25/2015 09:01:19,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 09:08:32,1642947700,5/25/2015 09:08:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 09:11:02,1642948002,5/25/2015 09:10:49,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatments,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
725446011,5/25/2015 09:12:09,1642948170,5/25/2015 09:11:29,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[IS_A]
[PART_OF]",A efficacy of,N/A,149,106,-1,157,119,TWrex-cause,803757-FS1,"Aznar J, Prados R, Rodriquez Pichardo A et al. Comparative clinical efficacy of two different single dose CIPROFLOXACIN treatments for uncomplicated GONORRHEA",GONORRHEA,CIPROFLOXACIN
